GO biological process complete,Homo sapiens - REFLIST (20595),upload_1 (1855),upload_1 (expected),upload_1 (over/under),upload_1 (fold Enrichment),upload_1 (raw P-value),upload_1 (FDR)
positive regulation of early endosome to late endosome transport (GO:2000643),8,6,0.72,+,8.33,5.30E-04,1.05E-02
ribonucleoprotein complex disassembly (GO:0032988),7,5,0.63,+,7.93,1.85E-03,3.06E-02
regulation of Rab protein signal transduction (GO:0032483),7,5,0.63,+,7.93,1.85E-03,3.06E-02
ESCRT III complex disassembly (GO:1904903),10,7,0.9,+,7.77,2.41E-04,5.38E-03
ESCRT complex disassembly (GO:1904896),10,7,0.9,+,7.77,2.41E-04,5.38E-03
regulation of endodeoxyribonuclease activity (GO:0032071),8,5,0.72,+,6.94,2.80E-03,4.28E-02
stress granule assembly (GO:0034063),20,12,1.8,+,6.66,4.61E-06,1.59E-04
regulation of deoxyribonuclease activity (GO:0032070),10,6,0.9,+,6.66,1.22E-03,2.17E-02
nuclear pore organization (GO:0006999),14,8,1.26,+,6.34,2.38E-04,5.35E-03
hippo signaling (GO:0035329),28,16,2.52,+,6.34,1.97E-07,8.95E-06
protein localization to cell-cell junction (GO:0150105),18,10,1.62,+,6.17,4.74E-05,1.29E-03
hepatocyte apoptotic process (GO:0097284),11,6,0.99,+,6.06,1.76E-03,2.93E-02
regulation of RNA export from nucleus (GO:0046831),13,7,1.17,+,5.98,7.69E-04,1.47E-02
histone H4-K16 acetylation (GO:0043984),15,8,1.35,+,5.92,3.39E-04,7.24E-03
microtubule anchoring at microtubule organizing center (GO:0072393),12,6,1.08,+,5.55,2.46E-03,3.87E-02
regulation of podosome assembly (GO:0071801),12,6,1.08,+,5.55,2.46E-03,3.87E-02
establishment of endothelial intestinal barrier (GO:0090557),12,6,1.08,+,5.55,2.46E-03,3.86E-02
regulation of protein K63-linked ubiquitination (GO:1900044),12,6,1.08,+,5.55,2.46E-03,3.86E-02
asymmetric cell division (GO:0008356),16,8,1.44,+,5.55,4.72E-04,9.59E-03
platelet formation (GO:0030220),18,9,1.62,+,5.55,2.09E-04,4.72E-03
actin filament depolymerization (GO:0030042),12,6,1.08,+,5.55,2.46E-03,3.85E-02
centriole-centriole cohesion (GO:0010457),12,6,1.08,+,5.55,2.46E-03,3.85E-02
positive regulation of receptor recycling (GO:0001921),14,7,1.26,+,5.55,1.07E-03,1.95E-02
regulation of early endosome to late endosome transport (GO:2000641),19,9,1.71,+,5.26,2.86E-04,6.23E-03
platelet morphogenesis (GO:0036344),19,9,1.71,+,5.26,2.86E-04,6.22E-03
GMP metabolic process (GO:0046037),15,7,1.35,+,5.18,1.46E-03,2.50E-02
postsynaptic actin cytoskeleton organization (GO:0098974),13,6,1.17,+,5.12,3.34E-03,4.90E-02
regulation of modification of synaptic structure (GO:1905244),13,6,1.17,+,5.12,3.34E-03,4.90E-02
positive regulation of cytoplasmic transport (GO:1903651),13,6,1.17,+,5.12,3.34E-03,4.89E-02
centrosome localization (GO:0051642),31,14,2.79,+,5.01,9.46E-06,3.05E-04
nuclear migration (GO:0007097),20,9,1.8,+,5,3.84E-04,8.04E-03
pore complex assembly (GO:0046931),20,9,1.8,+,5,3.84E-04,8.02E-03
regulation of necroptotic process (GO:0060544),27,12,2.43,+,4.93,4.63E-05,1.26E-03
histone H4-K8 acetylation (GO:0043982),16,7,1.44,+,4.86,1.95E-03,3.19E-02
histone H4-K5 acetylation (GO:0043981),16,7,1.44,+,4.86,1.95E-03,3.19E-02
regulation of nucleobase-containing compound transport (GO:0032239),16,7,1.44,+,4.86,1.95E-03,3.18E-02
microtubule organizing center localization (GO:0061842),32,14,2.88,+,4.86,1.26E-05,3.91E-04
protein kinase A signaling (GO:0010737),16,7,1.44,+,4.86,1.95E-03,3.18E-02
"mRNA cis splicing, via spliceosome (GO:0045292)",21,9,1.89,+,4.76,5.09E-04,1.02E-02
bone cell development (GO:0098751),21,9,1.89,+,4.76,5.09E-04,1.02E-02
regulation of centriole replication (GO:0046599),21,9,1.89,+,4.76,5.09E-04,1.02E-02
microtubule anchoring (GO:0034453),26,11,2.34,+,4.7,1.35E-04,3.24E-03
NLS-bearing protein import into nucleus (GO:0006607),19,8,1.71,+,4.67,1.14E-03,2.05E-02
regulation of mitotic spindle assembly (GO:1901673),19,8,1.71,+,4.67,1.14E-03,2.05E-02
cortical actin cytoskeleton organization (GO:0030866),38,16,3.42,+,4.67,4.51E-06,1.56E-04
positive regulation of microtubule polymerization (GO:0031116),31,13,2.79,+,4.66,3.64E-05,1.01E-03
establishment of monopolar cell polarity (GO:0061162),24,10,2.16,+,4.63,2.99E-04,6.49E-03
regulation of nuclease activity (GO:0032069),22,9,1.98,+,4.54,6.65E-04,1.29E-02
histone H3 deacetylation (GO:0070932),20,8,1.8,+,4.44,1.48E-03,2.52E-02
vesicle-mediated transport between endosomal compartments (GO:0098927),25,10,2.25,+,4.44,3.88E-04,8.09E-03
regulation of programmed necrotic cell death (GO:0062098),30,12,2.7,+,4.44,1.04E-04,2.55E-03
establishment or maintenance of monopolar cell polarity (GO:0061339),25,10,2.25,+,4.44,3.88E-04,8.08E-03
regulation of cytoplasmic transport (GO:1903649),28,11,2.52,+,4.36,2.27E-04,5.11E-03
regulation of receptor recycling (GO:0001919),23,9,2.07,+,4.34,8.58E-04,1.61E-02
early endosome to late endosome transport (GO:0045022),23,9,2.07,+,4.34,8.58E-04,1.61E-02
positive regulation of insulin receptor signaling pathway (GO:0046628),23,9,2.07,+,4.34,8.58E-04,1.61E-02
ciliary basal body-plasma membrane docking (GO:0097711),95,37,8.56,+,4.32,1.97E-11,1.56E-09
positive regulation of transcription of Notch receptor target (GO:0007221),18,7,1.62,+,4.32,3.31E-03,4.87E-02
protein depolymerization (GO:0051261),36,14,3.24,+,4.32,3.59E-05,9.99E-04
regulation of chromatin assembly or disassembly (GO:0001672),26,10,2.34,+,4.27,4.98E-04,1.01E-02
nucleus localization (GO:0051647),26,10,2.34,+,4.27,4.98E-04,1.01E-02
regulation of spindle assembly (GO:0090169),26,10,2.34,+,4.27,4.98E-04,1.00E-02
positive regulation of cellular response to insulin stimulus (GO:1900078),26,10,2.34,+,4.27,4.98E-04,1.00E-02
actin filament-based transport (GO:0099515),21,8,1.89,+,4.23,1.90E-03,3.12E-02
"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",21,8,1.89,+,4.23,1.90E-03,3.12E-02
regulation of chromatin assembly (GO:0010847),21,8,1.89,+,4.23,1.90E-03,3.12E-02
retrograde axonal transport (GO:0008090),21,8,1.89,+,4.23,1.90E-03,3.11E-02
positive regulation of lamellipodium assembly (GO:0010592),29,11,2.61,+,4.21,2.90E-04,6.31E-03
positive regulation of lamellipodium organization (GO:1902745),37,14,3.33,+,4.2,4.57E-05,1.25E-03
regulation of bicellular tight junction assembly (GO:2000810),24,9,2.16,+,4.16,1.09E-03,1.99E-02
positive regulation of protein deacetylation (GO:0090312),24,9,2.16,+,4.16,1.09E-03,1.99E-02
positive regulation of microtubule polymerization or depolymerization (GO:0031112),35,13,3.15,+,4.12,9.89E-05,2.49E-03
negative regulation of mRNA processing (GO:0050686),30,11,2.7,+,4.07,3.67E-04,7.70E-03
spindle localization (GO:0051653),55,20,4.95,+,4.04,1.90E-06,7.01E-05
regulation of sister chromatid cohesion (GO:0007063),22,8,1.98,+,4.04,2.40E-03,3.82E-02
barbed-end actin filament capping (GO:0051016),22,8,1.98,+,4.04,2.40E-03,3.81E-02
polarized epithelial cell differentiation (GO:0030859),22,8,1.98,+,4.04,2.40E-03,3.81E-02
establishment of apical/basal cell polarity (GO:0035089),22,8,1.98,+,4.04,2.40E-03,3.81E-02
establishment of spindle localization (GO:0051293),50,18,4.5,+,4,6.87E-06,2.30E-04
cellular response to epidermal growth factor stimulus (GO:0071364),45,16,4.05,+,3.95,2.49E-05,7.21E-04
establishment of epithelial cell polarity (GO:0090162),31,11,2.79,+,3.94,4.61E-04,9.38E-03
centriole replication (GO:0007099),23,8,2.07,+,3.86,3.01E-03,4.54E-02
protein localization to centrosome (GO:0071539),23,8,2.07,+,3.86,3.01E-03,4.54E-02
response to epidermal growth factor (GO:0070849),49,17,4.41,+,3.85,1.82E-05,5.46E-04
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),26,9,2.34,+,3.84,1.72E-03,2.88E-02
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),26,9,2.34,+,3.84,1.72E-03,2.88E-02
centriole assembly (GO:0098534),29,10,2.61,+,3.83,9.92E-04,1.82E-02
actin filament bundle assembly (GO:0051017),58,20,5.22,+,3.83,3.68E-06,1.29E-04
actin filament bundle organization (GO:0061572),61,21,5.49,+,3.82,2.16E-06,7.90E-05
establishment of mitotic spindle localization (GO:0040001),35,12,3.15,+,3.81,3.32E-04,7.10E-03
ncRNA export from nucleus (GO:0097064),38,13,3.42,+,3.8,1.93E-04,4.42E-03
histone deacetylation (GO:0016575),50,17,4.5,+,3.77,2.25E-05,6.60E-04
protein deacetylation (GO:0006476),53,18,4.77,+,3.77,1.32E-05,4.10E-04
regulation of microtubule polymerization (GO:0031113),53,18,4.77,+,3.77,1.32E-05,4.09E-04
negative regulation of stress fiber assembly (GO:0051497),27,9,2.43,+,3.7,2.13E-03,3.43E-02
positive regulation of protein import (GO:1904591),45,15,4.05,+,3.7,8.10E-05,2.08E-03
regulation of lamellipodium organization (GO:1902743),51,17,4.59,+,3.7,2.77E-05,7.88E-04
negative regulation of actin filament bundle assembly (GO:0032232),30,10,2.7,+,3.7,1.23E-03,2.17E-02
histone lysine demethylation (GO:0070076),30,10,2.7,+,3.7,1.23E-03,2.17E-02
establishment of mitotic spindle orientation (GO:0000132),30,10,2.7,+,3.7,1.23E-03,2.17E-02
regulation of lamellipodium assembly (GO:0010591),39,13,3.51,+,3.7,2.38E-04,5.34E-03
negative regulation of protein tyrosine kinase activity (GO:0061099),30,10,2.7,+,3.7,1.23E-03,2.16E-02
regulation of mitotic spindle organization (GO:0060236),36,12,3.24,+,3.7,4.10E-04,8.46E-03
histone H4 acetylation (GO:0043967),55,18,4.95,+,3.63,1.99E-05,5.95E-04
regulation of necrotic cell death (GO:0010939),40,13,3.6,+,3.61,2.92E-04,6.35E-03
multivesicular body sorting pathway (GO:0071985),37,12,3.33,+,3.6,5.03E-04,1.01E-02
protein demethylation (GO:0006482),34,11,3.06,+,3.59,8.68E-04,1.63E-02
vesicle cytoskeletal trafficking (GO:0099518),68,22,6.12,+,3.59,2.90E-06,1.03E-04
protein dealkylation (GO:0008214),34,11,3.06,+,3.59,8.68E-04,1.62E-02
establishment of endothelial barrier (GO:0061028),34,11,3.06,+,3.59,8.68E-04,1.62E-02
membrane docking (GO:0022406),180,58,16.21,+,3.58,3.79E-14,3.86E-12
epithelial cell apoptotic process (GO:1904019),28,9,2.52,+,3.57,2.61E-03,4.03E-02
establishment of cell polarity (GO:0030010),119,38,10.72,+,3.55,1.14E-09,7.11E-08
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),44,14,3.96,+,3.53,2.07E-04,4.69E-03
regulation of centrosome duplication (GO:0010824),44,14,3.96,+,3.53,2.07E-04,4.69E-03
cytoplasmic microtubule organization (GO:0031122),63,20,5.67,+,3.52,1.02E-05,3.24E-04
protein targeting to vacuole (GO:0006623),41,13,3.69,+,3.52,3.56E-04,7.56E-03
endocytic recycling (GO:0032456),41,13,3.69,+,3.52,3.56E-04,7.55E-03
negative regulation of actin filament depolymerization (GO:0030835),41,13,3.69,+,3.52,3.56E-04,7.54E-03
actin polymerization or depolymerization (GO:0008154),60,19,5.4,+,3.52,1.73E-05,5.26E-04
positive regulation of RNA splicing (GO:0033120),38,12,3.42,+,3.51,6.13E-04,1.20E-02
organelle localization by membrane tethering (GO:0140056),171,54,15.4,+,3.51,5.55E-13,5.21E-11
cytokinesis (GO:0000910),108,34,9.73,+,3.5,1.13E-08,6.16E-07
I-kappaB kinase/NF-kappaB signaling (GO:0007249),70,22,6.3,+,3.49,4.28E-06,1.49E-04
ERBB2 signaling pathway (GO:0038128),32,10,2.88,+,3.47,1.83E-03,3.04E-02
histone demethylation (GO:0016577),32,10,2.88,+,3.47,1.83E-03,3.03E-02
Rho protein signal transduction (GO:0007266),61,19,5.49,+,3.46,2.10E-05,6.25E-04
mitotic prometaphase (GO:0000236),167,52,15.04,+,3.46,2.32E-12,2.05E-10
telomere maintenance via telomerase (GO:0007004),29,9,2.61,+,3.45,3.18E-03,4.72E-02
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",58,18,5.22,+,3.45,3.57E-05,9.99E-04
cortical cytoskeleton organization (GO:0030865),58,18,5.22,+,3.45,3.57E-05,9.97E-04
positive regulation of protein import into nucleus (GO:0042307),42,13,3.78,+,3.44,4.31E-04,8.86E-03
mitotic cytokinesis (GO:0000281),68,21,6.12,+,3.43,8.77E-06,2.85E-04
virion assembly (GO:0019068),39,12,3.51,+,3.42,7.42E-04,1.42E-02
establishment or maintenance of apical/basal cell polarity (GO:0035088),49,15,4.41,+,3.4,1.77E-04,4.10E-03
establishment or maintenance of bipolar cell polarity (GO:0061245),49,15,4.41,+,3.4,1.77E-04,4.09E-03
negative regulation of telomere maintenance (GO:0032205),36,11,3.24,+,3.39,1.28E-03,2.24E-02
establishment of spindle orientation (GO:0051294),36,11,3.24,+,3.39,1.28E-03,2.24E-02
peptidyl-lysine acetylation (GO:0018394),118,36,10.63,+,3.39,8.36E-09,4.68E-07
regulation of protein deacetylation (GO:0090311),46,14,4.14,+,3.38,3.03E-04,6.54E-03
positive regulation of protein polymerization (GO:0032273),125,38,11.26,+,3.38,3.53E-09,2.05E-07
regulation of actin filament depolymerization (GO:0030834),56,17,5.04,+,3.37,7.33E-05,1.91E-03
regulation of protein depolymerization (GO:1901879),89,27,8.02,+,3.37,6.47E-07,2.67E-05
protein K48-linked deubiquitination (GO:0071108),33,10,2.97,+,3.36,2.21E-03,3.55E-02
lamellipodium organization (GO:0097581),43,13,3.87,+,3.36,5.20E-04,1.04E-02
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),53,16,4.77,+,3.35,1.25E-04,3.02E-03
mRNA transport (GO:0051028),159,48,14.32,+,3.35,3.93E-11,3.00E-09
positive regulation of DNA replication (GO:0045740),40,12,3.6,+,3.33,8.93E-04,1.67E-02
regulation of spindle organization (GO:0090224),40,12,3.6,+,3.33,8.93E-04,1.66E-02
mitotic spindle assembly (GO:0090307),47,14,4.23,+,3.31,3.64E-04,7.67E-03
regulation of mRNA processing (GO:0050684),141,42,12.7,+,3.31,8.99E-10,5.76E-08
negative regulation of cell-matrix adhesion (GO:0001953),37,11,3.33,+,3.3,1.54E-03,2.61E-02
actin filament capping (GO:0051693),37,11,3.33,+,3.3,1.54E-03,2.60E-02
intracellular transport of virus (GO:0075733),54,16,4.86,+,3.29,1.50E-04,3.54E-03
internal peptidyl-lysine acetylation (GO:0018393),115,34,10.36,+,3.28,4.08E-08,2.11E-06
platelet aggregation (GO:0070527),44,13,3.96,+,3.28,6.23E-04,1.22E-02
vesicle transport along microtubule (GO:0047496),44,13,3.96,+,3.28,6.23E-04,1.21E-02
regulation of RNA splicing (GO:0043484),149,44,13.42,+,3.28,4.52E-10,3.02E-08
regulation of interferon-beta production (GO:0032648),51,15,4.59,+,3.27,2.55E-04,5.63E-03
"regulation of mRNA splicing, via spliceosome (GO:0048024)",102,30,9.19,+,3.27,2.75E-07,1.23E-05
regulation of type I interferon-mediated signaling pathway (GO:0060338),34,10,3.06,+,3.27,2.65E-03,4.08E-02
negative regulation of protein depolymerization (GO:1901880),68,20,6.12,+,3.27,2.57E-05,7.41E-04
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),34,10,3.06,+,3.27,2.65E-03,4.08E-02
tRNA export from nucleus (GO:0006409),34,10,3.06,+,3.27,2.65E-03,4.07E-02
production of small RNA involved in gene silencing by RNA (GO:0070918),34,10,3.06,+,3.27,2.65E-03,4.07E-02
dsRNA processing (GO:0031050),34,10,3.06,+,3.27,2.65E-03,4.06E-02
histone acetylation (GO:0016573),109,32,9.82,+,3.26,1.16E-07,5.51E-06
post-transcriptional gene silencing by RNA (GO:0035194),58,17,5.22,+,3.25,1.05E-04,2.59E-03
positive regulation of axon extension (GO:0045773),41,12,3.69,+,3.25,1.07E-03,1.95E-02
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),106,31,9.55,+,3.25,1.95E-07,8.87E-06
positive regulation of protein localization to nucleus (GO:1900182),89,26,8.02,+,3.24,1.86E-06,6.90E-05
gene silencing by miRNA (GO:0035195),48,14,4.32,+,3.24,4.35E-04,8.93E-03
regulation of centrosome cycle (GO:0046605),48,14,4.32,+,3.24,4.35E-04,8.91E-03
regulation of cellular response to heat (GO:1900034),79,23,7.12,+,3.23,7.53E-06,2.49E-04
internal protein amino acid acetylation (GO:0006475),117,34,10.54,+,3.23,5.78E-08,2.88E-06
cytosolic transport (GO:0016482),148,43,13.33,+,3.23,1.08E-09,6.79E-08
regulation of cell-substrate junction organization (GO:0150116),69,20,6.21,+,3.22,3.06E-05,8.64E-04
positive regulation of histone methylation (GO:0031062),38,11,3.42,+,3.21,1.84E-03,3.04E-02
negative regulation of type I interferon production (GO:0032480),45,13,4.05,+,3.21,7.43E-04,1.42E-02
mRNA export from nucleus (GO:0006406),111,32,10,+,3.2,1.63E-07,7.55E-06
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),111,32,10,+,3.2,1.63E-07,7.53E-06
regulation of cellular response to insulin stimulus (GO:1900076),66,19,5.94,+,3.2,5.17E-05,1.39E-03
positive regulation of nucleocytoplasmic transport (GO:0046824),66,19,5.94,+,3.2,5.17E-05,1.38E-03
positive regulation of interferon-beta production (GO:0032728),35,10,3.15,+,3.17,3.16E-03,4.72E-02
cytokinetic process (GO:0032506),35,10,3.15,+,3.17,3.16E-03,4.72E-02
axon extension (GO:0048675),35,10,3.15,+,3.17,3.16E-03,4.72E-02
neuron projection organization (GO:0106027),42,12,3.78,+,3.17,1.27E-03,2.23E-02
centrosome duplication (GO:0051298),35,10,3.15,+,3.17,3.16E-03,4.71E-02
modulation by symbiont of host cellular process (GO:0044068),35,10,3.15,+,3.17,3.16E-03,4.71E-02
posttranscriptional gene silencing (GO:0016441),63,18,5.67,+,3.17,8.75E-05,2.23E-03
regulation of telomere maintenance (GO:0032204),81,23,7.3,+,3.15,1.06E-05,3.36E-04
apical junction assembly (GO:0043297),67,19,6.03,+,3.15,6.13E-05,1.62E-03
ribonucleoprotein complex export from nucleus (GO:0071426),127,36,11.44,+,3.15,4.04E-08,2.10E-06
establishment or maintenance of cell polarity (GO:0007163),195,55,17.56,+,3.13,1.38E-11,1.13E-09
RNA export from nucleus (GO:0006405),135,38,12.16,+,3.13,2.00E-08,1.06E-06
regulation of focal adhesion assembly (GO:0051893),64,18,5.76,+,3.12,1.04E-04,2.57E-03
ribonucleoprotein complex localization (GO:0071166),128,36,11.53,+,3.12,4.77E-08,2.44E-06
regulation of cell-substrate junction assembly (GO:0090109),64,18,5.76,+,3.12,1.04E-04,2.56E-03
regulation of mRNA stability (GO:0043488),192,54,17.29,+,3.12,2.32E-11,1.82E-09
protein deacylation (GO:0035601),64,18,5.76,+,3.12,1.04E-04,2.56E-03
microtubule organizing center organization (GO:0031023),100,28,9.01,+,3.11,1.54E-06,5.86E-05
regulation of insulin receptor signaling pathway (GO:0046626),68,19,6.12,+,3.1,7.24E-05,1.88E-03
purine nucleoside monophosphate metabolic process (GO:0009126),43,12,3.87,+,3.1,1.51E-03,2.56E-02
endosomal transport (GO:0016197),233,65,20.99,+,3.1,2.96E-13,2.81E-11
transport of virus (GO:0046794),61,17,5.49,+,3.09,1.75E-04,4.06E-03
RNA transport (GO:0050658),201,56,18.1,+,3.09,1.35E-11,1.12E-09
nucleic acid transport (GO:0050657),201,56,18.1,+,3.09,1.35E-11,1.11E-09
organelle transport along microtubule (GO:0072384),79,22,7.12,+,3.09,2.11E-05,6.25E-04
negative regulation of protein-containing complex disassembly (GO:0043242),79,22,7.12,+,3.09,2.11E-05,6.24E-04
regulation of microtubule polymerization or depolymerization (GO:0031110),83,23,7.48,+,3.08,1.47E-05,4.54E-04
regulation of protein import (GO:1904589),65,18,5.85,+,3.07,1.22E-04,2.97E-03
regulation of filopodium assembly (GO:0051489),47,13,4.23,+,3.07,1.04E-03,1.91E-02
positive regulation of chromatin organization (GO:1905269),116,32,10.45,+,3.06,3.74E-07,1.63E-05
establishment of RNA localization (GO:0051236),203,56,18.28,+,3.06,1.87E-11,1.51E-09
regulation of mRNA catabolic process (GO:0061013),214,59,19.28,+,3.06,5.53E-12,4.69E-10
purine ribonucleoside monophosphate metabolic process (GO:0009167),40,11,3.6,+,3.05,2.58E-03,3.99E-02
regulation of telomere maintenance via telomere lengthening (GO:1904356),62,17,5.58,+,3.04,2.06E-04,4.68E-03
regulation of mRNA metabolic process (GO:1903311),340,93,30.62,+,3.04,6.28E-18,9.34E-16
positive regulation of actin filament polymerization (GO:0030838),88,24,7.93,+,3.03,1.21E-05,3.80E-04
negative regulation of mRNA metabolic process (GO:1903312),88,24,7.93,+,3.03,1.21E-05,3.80E-04
regulation of RNA stability (GO:0043487),202,55,18.19,+,3.02,4.30E-11,3.23E-09
vesicle targeting (GO:0006903),92,25,8.29,+,3.02,8.49E-06,2.77E-04
ERBB signaling pathway (GO:0038127),70,19,6.3,+,3.01,1.00E-04,2.51E-03
nuclear export (GO:0051168),166,45,14.95,+,3.01,2.76E-09,1.62E-07
multi-organism localization (GO:1902579),63,17,5.67,+,3,2.42E-04,5.40E-03
multi-organism transport (GO:0044766),63,17,5.67,+,3,2.42E-04,5.39E-03
regulation of microtubule cytoskeleton organization (GO:0070507),141,38,12.7,+,2.99,5.25E-08,2.65E-06
vesicle coating (GO:0006901),67,18,6.03,+,2.98,1.68E-04,3.92E-03
activation of JUN kinase activity (GO:0007257),41,11,3.69,+,2.98,3.03E-03,4.56E-02
ephrin receptor signaling pathway (GO:0048013),86,23,7.75,+,2.97,2.38E-05,6.94E-04
activation of GTPase activity (GO:0090630),116,31,10.45,+,2.97,1.00E-06,4.01E-05
regulation of protein polymerization (GO:0032271),232,62,20.9,+,2.97,4.91E-12,4.18E-10
"retrograde transport, endosome to Golgi (GO:0042147)",90,24,8.11,+,2.96,1.66E-05,5.06E-04
regulation of dendritic spine morphogenesis (GO:0061001),45,12,4.05,+,2.96,2.08E-03,3.37E-02
actin filament organization (GO:0007015),270,72,24.32,+,2.96,1.03E-13,1.02E-11
regulation of dendritic spine development (GO:0060998),60,16,5.4,+,2.96,4.08E-04,8.41E-03
regulation of protein-containing complex disassembly (GO:0043244),124,33,11.17,+,2.95,4.93E-07,2.09E-05
RNA localization (GO:0006403),222,59,20,+,2.95,1.94E-11,1.55E-09
regulation of antigen receptor-mediated signaling pathway (GO:0050854),64,17,5.76,+,2.95,2.83E-04,6.18E-03
response to interleukin-12 (GO:0070671),49,13,4.41,+,2.95,1.44E-03,2.46E-02
actin cytoskeleton organization (GO:0030036),524,139,47.2,+,2.95,3.96E-25,1.25E-22
microtubule cytoskeleton organization involved in mitosis (GO:1902850),185,49,16.66,+,2.94,1.07E-09,6.75E-08
macromolecule deacylation (GO:0098732),68,18,6.12,+,2.94,1.97E-04,4.49E-03
establishment of organelle localization (GO:0051656),397,105,35.76,+,2.94,4.31E-19,7.47E-17
positive regulation of chromosome organization (GO:2001252),174,46,15.67,+,2.94,3.60E-09,2.08E-07
negative regulation of ERBB signaling pathway (GO:1901185),53,14,4.77,+,2.93,9.92E-04,1.82E-02
regulation of nucleocytoplasmic transport (GO:0046822),110,29,9.91,+,2.93,2.78E-06,9.94E-05
protein export from nucleus (GO:0006611),152,40,13.69,+,2.92,4.10E-08,2.11E-06
RNA stabilization (GO:0043489),57,15,5.13,+,2.92,6.86E-04,1.32E-02
protein acetylation (GO:0006473),137,36,12.34,+,2.92,1.97E-07,8.97E-06
vesicle budding from membrane (GO:0006900),103,27,9.28,+,2.91,6.61E-06,2.22E-04
centrosome cycle (GO:0007098),88,23,7.93,+,2.9,3.23E-05,9.08E-04
interleukin-12-mediated signaling pathway (GO:0035722),46,12,4.14,+,2.9,2.43E-03,3.84E-02
cytoskeleton-dependent cytokinesis (GO:0061640),96,25,8.65,+,2.89,1.57E-05,4.82E-04
epidermal growth factor receptor signaling pathway (GO:0007173),50,13,4.5,+,2.89,1.67E-03,2.81E-02
regulation of telomerase activity (GO:0051972),50,13,4.5,+,2.89,1.67E-03,2.81E-02
positive regulation of blood vessel endothelial cell migration (GO:0043536),54,14,4.86,+,2.88,1.16E-03,2.07E-02
nuclear envelope reassembly (GO:0031468),54,14,4.86,+,2.88,1.16E-03,2.07E-02
establishment of vesicle localization (GO:0051650),201,52,18.1,+,2.87,9.61E-10,6.14E-08
"vesicle targeting, to, from or within Golgi (GO:0048199)",70,18,6.3,+,2.85,2.66E-04,5.86E-03
G2/M transition of mitotic cell cycle (GO:0000086),140,36,12.61,+,2.85,3.08E-07,1.37E-05
organelle localization (GO:0051640),616,158,55.48,+,2.85,3.41E-27,1.34E-24
regulation of G2/M transition of mitotic cell cycle (GO:0010389),203,52,18.28,+,2.84,1.14E-09,7.09E-08
negative regulation of translation (GO:0017148),137,35,12.34,+,2.84,5.10E-07,2.16E-05
establishment of protein localization to plasma membrane (GO:0061951),47,12,4.23,+,2.83,2.83E-03,4.31E-02
positive regulation of telomere maintenance (GO:0032206),51,13,4.59,+,2.83,1.95E-03,3.19E-02
homotypic cell-cell adhesion (GO:0034109),59,15,5.31,+,2.82,9.27E-04,1.72E-02
positive regulation of apoptotic signaling pathway (GO:2001235),122,31,10.99,+,2.82,2.46E-06,8.91E-05
regulation of actin polymerization or depolymerization (GO:0008064),189,48,17.02,+,2.82,6.15E-09,3.50E-07
COPII vesicle coating (GO:0048208),63,16,5.67,+,2.82,6.41E-04,1.25E-02
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",63,16,5.67,+,2.82,6.41E-04,1.24E-02
cytoskeleton-dependent intracellular transport (GO:0030705),193,49,17.38,+,2.82,4.24E-09,2.43E-07
positive regulation of organelle assembly (GO:1902117),67,17,6.03,+,2.82,4.44E-04,9.08E-03
actin cytoskeleton reorganization (GO:0031532),67,17,6.03,+,2.82,4.44E-04,9.07E-03
cell cycle G2/M phase transition (GO:0044839),142,36,12.79,+,2.81,6.14E-07,2.55E-05
vascular endothelial growth factor receptor signaling pathway (GO:0048010),71,18,6.39,+,2.81,3.08E-04,6.61E-03
spindle organization (GO:0007051),225,57,20.27,+,2.81,2.24E-10,1.54E-08
negative regulation of chromosome organization (GO:2001251),79,20,7.12,+,2.81,1.49E-04,3.53E-03
regulation of glycolytic process (GO:0006110),79,20,7.12,+,2.81,1.49E-04,3.52E-03
nuclear envelope organization (GO:0006998),83,21,7.48,+,2.81,1.04E-04,2.57E-03
biological phase (GO:0044848),257,65,23.15,+,2.81,1.23E-11,1.03E-09
mitotic cell cycle phase (GO:0098763),257,65,23.15,+,2.81,1.23E-11,1.02E-09
cell cycle phase (GO:0022403),257,65,23.15,+,2.81,1.23E-11,1.02E-09
histone modification (GO:0016570),356,90,32.07,+,2.81,1.83E-15,2.15E-13
covalent chromatin modification (GO:0016569),360,91,32.43,+,2.81,1.25E-15,1.51E-13
regulation of actin filament length (GO:0030832),190,48,17.11,+,2.8,6.81E-09,3.84E-07
positive regulation of cellular protein localization (GO:1903829),301,76,27.11,+,2.8,2.31E-13,2.22E-11
regulation of cell projection assembly (GO:0060491),187,47,16.84,+,2.79,1.10E-08,6.01E-07
regulation of chromatin organization (GO:1902275),203,51,18.28,+,2.79,2.54E-09,1.49E-07
regulation of cell cycle G2/M phase transition (GO:1902749),219,55,19.73,+,2.79,5.92E-10,3.92E-08
regulation of GTPase activity (GO:0043087),490,123,44.13,+,2.79,1.07E-20,2.37E-18
actin filament-based process (GO:0030029),598,150,53.86,+,2.78,5.58E-25,1.66E-22
regulation of supramolecular fiber organization (GO:1902903),375,94,33.78,+,2.78,5.36E-16,6.71E-14
positive regulation of DNA repair (GO:0045739),76,19,6.85,+,2.78,2.47E-04,5.48E-03
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),48,12,4.32,+,2.78,3.27E-03,4.85E-02
sister chromatid cohesion (GO:0007062),48,12,4.32,+,2.78,3.27E-03,4.84E-02
cellular response to interleukin-12 (GO:0071349),48,12,4.32,+,2.78,3.27E-03,4.84E-02
negative regulation of cytoskeleton organization (GO:0051494),152,38,13.69,+,2.78,3.39E-07,1.50E-05
tight junction assembly (GO:0120192),60,15,5.4,+,2.78,1.07E-03,1.95E-02
negative regulation of actin filament polymerization (GO:0030837),60,15,5.4,+,2.78,1.07E-03,1.95E-02
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),48,12,4.32,+,2.78,3.27E-03,4.84E-02
regulation of histone acetylation (GO:0035065),56,14,5.04,+,2.78,1.55E-03,2.63E-02
mitotic nuclear division (GO:0140014),209,52,18.82,+,2.76,2.25E-09,1.35E-07
positive regulation of supramolecular fiber organization (GO:1902905),197,49,17.74,+,2.76,6.66E-09,3.77E-07
regulation of plasma membrane bounded cell projection assembly (GO:0120032),185,46,16.66,+,2.76,1.98E-08,1.06E-06
regulation of actin filament polymerization (GO:0030833),173,43,15.58,+,2.76,5.93E-08,2.95E-06
regulation of protein localization to nucleus (GO:1900180),137,34,12.34,+,2.76,1.66E-06,6.27E-05
positive regulation of cytoskeleton organization (GO:0051495),214,53,19.28,+,2.75,1.78E-09,1.09E-07
regulation of carbohydrate catabolic process (GO:0043470),89,22,8.02,+,2.74,9.57E-05,2.42E-03
positive regulation of GTPase activity (GO:0043547),413,102,37.2,+,2.74,9.39E-17,1.26E-14
vesicle localization (GO:0051648),211,52,19,+,2.74,2.90E-09,1.69E-07
positive regulation of JUN kinase activity (GO:0043507),69,17,6.21,+,2.74,5.91E-04,1.16E-02
positive regulation of protein localization to cell periphery (GO:1904377),69,17,6.21,+,2.74,5.91E-04,1.16E-02
S phase (GO:0051320),65,16,5.85,+,2.73,8.54E-04,1.61E-02
positive regulation of protein localization to membrane (GO:1905477),130,32,11.71,+,2.73,3.83E-06,1.34E-04
mitotic S phase (GO:0000084),65,16,5.85,+,2.73,8.54E-04,1.61E-02
ribonucleoside diphosphate metabolic process (GO:0009185),65,16,5.85,+,2.73,8.54E-04,1.61E-02
regulation of organelle assembly (GO:1902115),191,47,17.2,+,2.73,1.75E-08,9.42E-07
regulation of protein import into nucleus (GO:0042306),61,15,5.49,+,2.73,1.23E-03,2.17E-02
spliceosomal complex assembly (GO:0000245),57,14,5.13,+,2.73,1.79E-03,2.98E-02
ribonucleoside monophosphate metabolic process (GO:0009161),57,14,5.13,+,2.73,1.79E-03,2.98E-02
endosome to lysosome transport (GO:0008333),53,13,4.77,+,2.72,2.60E-03,4.02E-02
establishment of protein localization to vacuole (GO:0072666),53,13,4.77,+,2.72,2.60E-03,4.01E-02
positive regulation of mRNA catabolic process (GO:0061014),53,13,4.77,+,2.72,2.60E-03,4.01E-02
positive regulation of protein-containing complex assembly (GO:0031334),249,61,22.43,+,2.72,2.07E-10,1.44E-08
small GTPase mediated signal transduction (GO:0007264),262,64,23.6,+,2.71,7.32E-11,5.42E-09
cell-cell junction assembly (GO:0007043),127,31,11.44,+,2.71,6.11E-06,2.06E-04
mitotic spindle organization (GO:0007052),164,40,14.77,+,2.71,2.50E-07,1.12E-05
regulation of lipid kinase activity (GO:0043550),70,17,6.3,+,2.7,6.79E-04,1.31E-02
positive regulation of intracellular transport (GO:0032388),227,55,20.45,+,2.69,2.26E-09,1.35E-07
positive regulation of protein localization to plasma membrane (GO:1903078),62,15,5.58,+,2.69,1.42E-03,2.45E-02
positive regulation of intracellular protein transport (GO:0090316),186,45,16.75,+,2.69,5.24E-08,2.65E-06
tight junction organization (GO:0120193),62,15,5.58,+,2.69,1.42E-03,2.44E-02
purine ribonucleoside diphosphate metabolic process (GO:0009179),62,15,5.58,+,2.69,1.42E-03,2.44E-02
purine nucleoside diphosphate metabolic process (GO:0009135),62,15,5.58,+,2.69,1.42E-03,2.44E-02
spindle assembly (GO:0051225),91,22,8.2,+,2.68,1.83E-04,4.21E-03
activation of innate immune response (GO:0002218),149,36,13.42,+,2.68,1.20E-06,4.70E-05
nucleus organization (GO:0006997),145,35,13.06,+,2.68,1.72E-06,6.48E-05
negative regulation of NF-kappaB transcription factor activity (GO:0032088),87,21,7.84,+,2.68,2.69E-04,5.90E-03
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),58,14,5.22,+,2.68,2.05E-03,3.33E-02
regulation of telomere maintenance via telomerase (GO:0032210),54,13,4.86,+,2.67,2.98E-03,4.51E-02
cellular response to heat (GO:0034605),54,13,4.86,+,2.67,2.98E-03,4.51E-02
mitotic interphase (GO:0051329),79,19,7.12,+,2.67,5.84E-04,1.15E-02
interphase (GO:0051325),79,19,7.12,+,2.67,5.84E-04,1.15E-02
nuclear transport (GO:0051169),262,63,23.6,+,2.67,1.58E-10,1.12E-08
regulation of protein localization to plasma membrane (GO:1903076),104,25,9.37,+,2.67,6.31E-05,1.66E-03
regulation of chromosome organization (GO:0033044),283,68,25.49,+,2.67,2.90E-11,2.23E-09
nucleocytoplasmic transport (GO:0006913),259,62,23.33,+,2.66,2.54E-10,1.74E-08
cytoskeleton organization (GO:0007010),1204,288,108.44,+,2.66,5.97E-45,1.57E-41
regulation of actin filament organization (GO:0110053),276,66,24.86,+,2.65,6.72E-11,5.00E-09
regulation of dendrite morphogenesis (GO:0048814),67,16,6.03,+,2.65,1.12E-03,2.03E-02
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),67,16,6.03,+,2.65,1.12E-03,2.03E-02
chromatin remodeling (GO:0006338),172,41,15.49,+,2.65,2.83E-07,1.26E-05
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),59,14,5.31,+,2.63,2.35E-03,3.74E-02
regulation of protein acetylation (GO:1901983),76,18,6.85,+,2.63,9.13E-04,1.70E-02
response to dsRNA (GO:0043331),55,13,4.95,+,2.62,3.41E-03,4.98E-02
DNA duplex unwinding (GO:0032508),106,25,9.55,+,2.62,7.56E-05,1.96E-03
positive regulation of mRNA metabolic process (GO:1903313),85,20,7.66,+,2.61,4.54E-04,9.25E-03
regulation of signal transduction by p53 class mediator (GO:1901796),196,46,17.65,+,2.61,9.53E-08,4.65E-06
regulation of peptidyl-lysine acetylation (GO:2000756),64,15,5.76,+,2.6,2.94E-03,4.46E-02
regulation of type I interferon production (GO:0032479),128,30,11.53,+,2.6,1.49E-05,4.58E-04
vesicle docking (GO:0048278),64,15,5.76,+,2.6,2.94E-03,4.46E-02
regulation of cellular protein localization (GO:1903827),564,132,50.8,+,2.6,9.71E-20,1.82E-17
endosome organization (GO:0007032),77,18,6.94,+,2.6,9.75E-04,1.80E-02
negative regulation of supramolecular fiber organization (GO:1902904),154,36,13.87,+,2.6,3.39E-06,1.19E-04
regulation of establishment of protein localization to mitochondrion (GO:1903747),73,17,6.58,+,2.59,1.43E-03,2.46E-02
negative regulation of RNA catabolic process (GO:1902369),69,16,6.21,+,2.57,2.11E-03,3.41E-02
protein localization to vacuole (GO:0072665),69,16,6.21,+,2.57,2.11E-03,3.40E-02
axo-dendritic transport (GO:0008088),69,16,6.21,+,2.57,2.11E-03,3.40E-02
vacuolar transport (GO:0007034),151,35,13.6,+,2.57,5.20E-06,1.79E-04
protein localization to nucleus (GO:0034504),164,38,14.77,+,2.57,1.81E-06,6.76E-05
regulation of cytoskeleton organization (GO:0051493),519,120,46.75,+,2.57,1.09E-17,1.59E-15
viral process (GO:0016032),849,196,76.47,+,2.56,1.40E-28,6.32E-26
protein sumoylation (GO:0016925),65,15,5.85,+,2.56,3.11E-03,4.66E-02
positive regulation of histone modification (GO:0031058),91,21,8.2,+,2.56,3.68E-04,7.71E-03
actomyosin structure organization (GO:0031032),104,24,9.37,+,2.56,1.33E-04,3.20E-03
positive regulation of DNA metabolic process (GO:0051054),204,47,18.37,+,2.56,9.87E-08,4.79E-06
DNA geometric change (GO:0032392),113,26,10.18,+,2.55,7.12E-05,1.86E-03
regulation of intracellular transport (GO:0032386),361,83,32.52,+,2.55,1.48E-12,1.35E-10
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),87,20,7.84,+,2.55,5.35E-04,1.06E-02
negative regulation of protein polymerization (GO:0032272),74,17,6.67,+,2.55,1.54E-03,2.61E-02
regulation of histone modification (GO:0031056),148,34,13.33,+,2.55,7.99E-06,2.63E-04
"RNA splicing, via transesterification reactions (GO:0000375)",305,70,27.47,+,2.55,1.30E-10,9.27E-09
lysosomal transport (GO:0007041),109,25,9.82,+,2.55,1.03E-04,2.56E-03
positive regulation of organelle organization (GO:0010638),590,135,53.14,+,2.54,1.61E-19,2.96E-17
COPII-coated vesicle budding (GO:0090114),70,16,6.3,+,2.54,2.25E-03,3.60E-02
"mRNA splicing, via spliceosome (GO:0000398)",302,69,27.2,+,2.54,1.98E-10,1.39E-08
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",302,69,27.2,+,2.54,1.98E-10,1.39E-08
protein autophosphorylation (GO:0046777),184,42,16.57,+,2.53,5.96E-07,2.48E-05
positive regulation of type I interferon production (GO:0032481),79,18,7.12,+,2.53,1.14E-03,2.05E-02
regulation of actin filament bundle assembly (GO:0032231),101,23,9.1,+,2.53,2.13E-04,4.81E-03
Ras protein signal transduction (GO:0007265),176,40,15.85,+,2.52,1.23E-06,4.78E-05
positive regulation of response to DNA damage stimulus (GO:2001022),110,25,9.91,+,2.52,1.14E-04,2.79E-03
regulation of DNA replication (GO:0006275),110,25,9.91,+,2.52,1.14E-04,2.79E-03
postsynapse organization (GO:0099173),88,20,7.93,+,2.52,5.86E-04,1.15E-02
maintenance of protein location in cell (GO:0032507),66,15,5.94,+,2.52,3.31E-03,4.87E-02
regulation of histone methylation (GO:0031060),66,15,5.94,+,2.52,3.31E-03,4.87E-02
maintenance of protein location (GO:0045185),97,22,8.74,+,2.52,3.08E-04,6.62E-03
negative regulation of cellular amide metabolic process (GO:0034249),159,36,14.32,+,2.51,4.77E-06,1.64E-04
vesicle-mediated transport to the plasma membrane (GO:0098876),84,19,7.57,+,2.51,8.51E-04,1.61E-02
developmental cell growth (GO:0048588),84,19,7.57,+,2.51,8.51E-04,1.61E-02
nucleobase-containing compound transport (GO:0015931),253,57,22.79,+,2.5,8.83E-09,4.92E-07
biological process involved in symbiotic interaction (GO:0044403),937,211,84.4,+,2.5,1.85E-29,8.57E-27
regulation of protein-containing complex assembly (GO:0043254),454,102,40.89,+,2.49,1.43E-14,1.50E-12
plasma membrane organization (GO:0007009),98,22,8.83,+,2.49,3.41E-04,7.27E-03
regulation of extrinsic apoptotic signaling pathway (GO:2001236),156,35,14.05,+,2.49,7.49E-06,2.49E-04
transport along microtubule (GO:0010970),156,35,14.05,+,2.49,7.49E-06,2.48E-04
regulation of ATP metabolic process (GO:1903578),116,26,10.45,+,2.49,9.91E-05,2.49E-03
regulation of protein localization to cell periphery (GO:1904375),125,28,11.26,+,2.49,7.87E-05,2.03E-03
regulation of cellular component size (GO:0032535),384,86,34.59,+,2.49,1.95E-12,1.75E-10
cell division (GO:0051301),492,110,44.31,+,2.48,1.99E-15,2.31E-13
regulation of JUN kinase activity (GO:0043506),85,19,7.66,+,2.48,9.33E-04,1.73E-02
maintenance of location in cell (GO:0051651),94,21,8.47,+,2.48,4.92E-04,9.97E-03
regulation of ERBB signaling pathway (GO:1901184),94,21,8.47,+,2.48,4.92E-04,9.96E-03
microtubule cytoskeleton organization (GO:0000226),566,126,50.98,+,2.47,1.89E-17,2.68E-15
viral life cycle (GO:0019058),225,50,20.27,+,2.47,1.08E-07,5.20E-06
mitotic cell cycle process (GO:1903047),685,152,61.7,+,2.46,1.04E-20,2.34E-18
regulation of DNA repair (GO:0006282),131,29,11.8,+,2.46,6.16E-05,1.62E-03
RNA splicing (GO:0008380),407,90,36.66,+,2.46,1.21E-12,1.11E-10
regulation of protein localization to membrane (GO:1905475),199,44,17.92,+,2.45,7.95E-07,3.23E-05
cell growth (GO:0016049),86,19,7.75,+,2.45,1.03E-03,1.88E-02
ATP-dependent chromatin remodeling (GO:0043044),77,17,6.94,+,2.45,1.96E-03,3.20E-02
regulation of cell morphogenesis (GO:0022604),308,68,27.74,+,2.45,1.02E-09,6.46E-08
cell-cell junction organization (GO:0045216),186,41,16.75,+,2.45,2.21E-06,8.06E-05
protein acylation (GO:0043543),177,39,15.94,+,2.45,4.36E-06,1.51E-04
platelet activation (GO:0030168),141,31,12.7,+,2.44,3.47E-05,9.73E-04
regulation of cell-matrix adhesion (GO:0001952),123,27,11.08,+,2.44,1.28E-04,3.09E-03
protein stabilization (GO:0050821),196,43,17.65,+,2.44,1.23E-06,4.79E-05
regulation of establishment of planar polarity (GO:0090175),114,25,10.27,+,2.43,2.52E-04,5.59E-03
protein import into nucleus (GO:0006606),96,21,8.65,+,2.43,6.03E-04,1.18E-02
peptidyl-lysine modification (GO:0018205),302,66,27.2,+,2.43,2.30E-09,1.37E-07
gene silencing by RNA (GO:0031047),87,19,7.84,+,2.42,1.13E-03,2.04E-02
ribonucleoprotein complex subunit organization (GO:0071826),197,43,17.74,+,2.42,1.33E-06,5.11E-05
positive regulation of cellular component biogenesis (GO:0044089),527,115,47.47,+,2.42,1.56E-15,1.87E-13
stress-activated protein kinase signaling cascade (GO:0031098),124,27,11.17,+,2.42,1.37E-04,3.28E-03
stimulatory C-type lectin receptor signaling pathway (GO:0002223),115,25,10.36,+,2.41,2.67E-04,5.88E-03
import into nucleus (GO:0051170),115,25,10.36,+,2.41,2.67E-04,5.87E-03
regulation of small GTPase mediated signal transduction (GO:0051056),327,71,29.45,+,2.41,5.52E-10,3.67E-08
regulation of intracellular protein transport (GO:0033157),258,56,23.24,+,2.41,3.86E-08,2.01E-06
mitotic cell cycle (GO:0000278),761,165,68.54,+,2.41,1.20E-21,2.91E-19
innate immune response-activating signal transduction (GO:0002758),120,26,10.81,+,2.41,1.98E-04,4.51E-03
anaphase (GO:0051322),157,34,14.14,+,2.4,2.70E-05,7.73E-04
mitotic anaphase (GO:0000090),157,34,14.14,+,2.4,2.70E-05,7.71E-04
post-Golgi vesicle-mediated transport (GO:0006892),134,29,12.07,+,2.4,7.78E-05,2.01E-03
pigmentation (GO:0043473),88,19,7.93,+,2.4,1.25E-03,2.20E-02
protein deubiquitination (GO:0016579),278,60,25.04,+,2.4,2.01E-08,1.06E-06
regulation of cell shape (GO:0008360),153,33,13.78,+,2.39,2.46E-05,7.14E-04
regulation of cell size (GO:0008361),181,39,16.3,+,2.39,5.55E-06,1.90E-04
Golgi organization (GO:0007030),135,29,12.16,+,2.38,8.49E-05,2.17E-03
modulation of process of other organism involved in symbiotic interaction (GO:0051817),117,25,10.54,+,2.37,3.05E-04,6.57E-03
regulation of actin cytoskeleton organization (GO:0032956),356,76,32.07,+,2.37,2.71E-10,1.82E-08
regulation of cytokinesis (GO:0032465),89,19,8.02,+,2.37,1.38E-03,2.40E-02
regulation of microtubule-based process (GO:0032886),235,50,21.17,+,2.36,3.52E-07,1.55E-05
M phase (GO:0000279),160,34,14.41,+,2.36,3.12E-05,8.81E-04
mitotic M phase (GO:0000087),160,34,14.41,+,2.36,3.12E-05,8.80E-04
negative regulation of organelle organization (GO:0010639),332,70,29.9,+,2.34,2.25E-09,1.35E-07
positive regulation of neuron projection development (GO:0010976),157,33,14.14,+,2.33,4.75E-05,1.29E-03
negative regulation of protein-containing complex assembly (GO:0031333),138,29,12.43,+,2.33,1.72E-04,4.00E-03
innate immune response activating cell surface receptor signaling pathway (GO:0002220),119,25,10.72,+,2.33,3.56E-04,7.53E-03
regulation of actin filament-based process (GO:0032970),396,83,35.67,+,2.33,8.28E-11,6.07E-09
regulation of organelle organization (GO:0033043),1188,249,107,+,2.33,1.19E-30,6.47E-28
chromatin organization (GO:0006325),697,146,62.78,+,2.33,4.43E-18,6.79E-16
microtubule-based transport (GO:0099111),191,40,17.2,+,2.33,9.58E-06,3.08E-04
regulation of double-strand break repair (GO:2000779),86,18,7.75,+,2.32,3.36E-03,4.91E-02
regulation of blood vessel endothelial cell migration (GO:0043535),91,19,8.2,+,2.32,2.43E-03,3.84E-02
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",120,25,10.81,+,2.31,3.87E-04,8.07E-03
sister chromatid segregation (GO:0000819),149,31,13.42,+,2.31,9.68E-05,2.45E-03
toll-like receptor signaling pathway (GO:0002224),101,21,9.1,+,2.31,1.31E-03,2.28E-02
regulation of cellular component biogenesis (GO:0044087),967,201,87.1,+,2.31,3.05E-24,8.76E-22
protein modification by small protein removal (GO:0070646),295,61,26.57,+,2.3,4.95E-08,2.52E-06
posttranscriptional regulation of gene expression (GO:0010608),547,113,49.27,+,2.29,7.75E-14,7.74E-12
regulation of actomyosin structure organization (GO:0110020),97,20,8.74,+,2.29,1.88E-03,3.10E-02
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",97,20,8.74,+,2.29,1.88E-03,3.10E-02
protein localization to plasma membrane (GO:0072659),195,40,17.56,+,2.28,1.19E-05,3.73E-04
regulation of dephosphorylation (GO:0035303),216,44,19.46,+,2.26,6.39E-06,2.15E-04
regulation of purine nucleotide metabolic process (GO:1900542),118,24,10.63,+,2.26,6.54E-04,1.27E-02
regulation of cellular localization (GO:0060341),836,170,75.3,+,2.26,9.84E-20,1.83E-17
microtubule-based process (GO:0007017),803,163,72.33,+,2.25,5.87E-19,9.96E-17
positive regulation of cell projection organization (GO:0031346),350,71,31.52,+,2.25,9.23E-09,5.13E-07
plasma membrane bounded cell projection assembly (GO:0120031),469,95,42.24,+,2.25,1.97E-11,1.57E-09
regulation of intrinsic apoptotic signaling pathway (GO:2001242),158,32,14.23,+,2.25,9.73E-05,2.45E-03
positive regulation of NF-kappaB transcription factor activity (GO:0051092),163,33,14.68,+,2.25,7.46E-05,1.93E-03
positive regulation of cellular component organization (GO:0051130),1135,229,102.23,+,2.24,4.26E-26,1.49E-23
actin filament-based movement (GO:0030048),119,24,10.72,+,2.24,1.07E-03,1.95E-02
regulation of protein stability (GO:0031647),303,61,27.29,+,2.24,1.24E-07,5.84E-06
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),105,21,9.46,+,2.22,1.74E-03,2.90E-02
mitotic cell cycle phase transition (GO:0044772),285,57,25.67,+,2.22,4.55E-07,1.96E-05
regulation of nucleotide metabolic process (GO:0006140),120,24,10.81,+,2.22,1.11E-03,2.01E-02
positive regulation of establishment of protein localization (GO:1904951),345,69,31.07,+,2.22,2.10E-08,1.11E-06
positive regulation of neuron death (GO:1901216),95,19,8.56,+,2.22,3.06E-03,4.61E-02
ribonucleoprotein complex assembly (GO:0022618),190,38,17.11,+,2.22,2.93E-05,8.29E-04
Golgi vesicle transport (GO:0048193),396,79,35.67,+,2.21,1.93E-09,1.17E-07
nuclear-transcribed mRNA catabolic process (GO:0000956),196,39,17.65,+,2.21,3.62E-05,1.01E-03
protein-containing complex localization (GO:0031503),257,51,23.15,+,2.2,1.77E-06,6.63E-05
mRNA processing (GO:0006397),484,96,43.59,+,2.2,4.06E-11,3.07E-09
mitotic sister chromatid segregation (GO:0000070),121,24,10.9,+,2.2,1.16E-03,2.07E-02
viral transcription (GO:0019083),116,23,10.45,+,2.2,1.58E-03,2.66E-02
regulation of DNA biosynthetic process (GO:2000278),111,22,10,+,2.2,2.17E-03,3.48E-02
regulation of mitotic cell cycle phase transition (GO:1901990),424,84,38.19,+,2.2,8.15E-10,5.27E-08
regulation of dendrite development (GO:0050773),101,20,9.1,+,2.2,2.48E-03,3.88E-02
regulation of pattern recognition receptor signaling pathway (GO:0062207),101,20,9.1,+,2.2,2.48E-03,3.88E-02
cell cycle phase transition (GO:0044770),293,58,26.39,+,2.2,3.83E-07,1.66E-05
response to heat (GO:0009408),96,19,8.65,+,2.2,3.28E-03,4.85E-02
regulation of axon extension (GO:0030516),96,19,8.65,+,2.2,3.28E-03,4.84E-02
pattern recognition receptor signaling pathway (GO:0002221),127,25,11.44,+,2.19,9.06E-04,1.69E-02
regulation of receptor-mediated endocytosis (GO:0048259),107,21,9.64,+,2.18,3.08E-03,4.63E-02
supramolecular fiber organization (GO:0097435),597,117,53.77,+,2.18,7.29E-13,6.80E-11
regulation of apoptotic signaling pathway (GO:2001233),347,68,31.25,+,2.18,6.45E-08,3.20E-06
cell projection assembly (GO:0030031),485,95,43.68,+,2.17,1.08E-10,7.89E-09
positive regulation of hydrolase activity (GO:0051345),777,152,69.98,+,2.17,1.76E-16,2.28E-14
positive regulation of cell growth (GO:0030307),164,32,14.77,+,2.17,2.02E-04,4.60E-03
negative regulation of cell cycle G2/M phase transition (GO:1902750),108,21,9.73,+,2.16,3.18E-03,4.73E-02
T cell receptor signaling pathway (GO:0050852),180,35,16.21,+,2.16,9.49E-05,2.41E-03
positive regulation of endothelial cell migration (GO:0010595),108,21,9.73,+,2.16,3.18E-03,4.73E-02
regulation of mitotic cell cycle (GO:0007346),588,114,52.96,+,2.15,2.32E-12,2.05E-10
vesicle organization (GO:0016050),310,60,27.92,+,2.15,4.71E-07,2.02E-05
regulation of phosphatase activity (GO:0010921),181,35,16.3,+,2.15,1.47E-04,3.49E-03
gene silencing (GO:0016458),150,29,13.51,+,2.15,5.11E-04,1.02E-02
Fc receptor signaling pathway (GO:0038093),238,46,21.44,+,2.15,1.03E-05,3.26E-04
chromosome organization (GO:0051276),1061,205,95.56,+,2.15,1.77E-21,4.22E-19
modulation of process of other organism (GO:0035821),145,28,13.06,+,2.14,6.91E-04,1.33E-02
positive regulation of apoptotic process (GO:0043065),549,106,49.45,+,2.14,1.65E-11,1.34E-09
regulation of DNA metabolic process (GO:0051052),373,72,33.6,+,2.14,4.11E-08,2.11E-06
regulation of catabolic process (GO:0009894),1021,197,91.96,+,2.14,1.31E-20,2.83E-18
cell junction assembly (GO:0034329),280,54,25.22,+,2.14,1.77E-06,6.62E-05
intracellular transport (GO:0046907),1499,289,135.02,+,2.14,2.48E-30,1.26E-27
positive regulation of DNA-binding transcription factor activity (GO:0051091),270,52,24.32,+,2.14,3.07E-06,1.08E-04
regulation of generation of precursor metabolites and energy (GO:0043467),161,31,14.5,+,2.14,3.02E-04,6.51E-03
regulation of protein localization (GO:0032880),899,173,80.97,+,2.14,4.50E-18,6.82E-16
organelle assembly (GO:0070925),781,150,70.34,+,2.13,1.02E-15,1.25E-13
response to ionizing radiation (GO:0010212),146,28,13.15,+,2.13,7.19E-04,1.38E-02
positive regulation of protein transport (GO:0051222),329,63,29.63,+,2.13,3.70E-07,1.62E-05
regulation of cell cycle phase transition (GO:1901987),462,88,41.61,+,2.11,1.55E-09,9.50E-08
regulation of cell cycle process (GO:0010564),772,147,69.53,+,2.11,4.65E-15,5.09E-13
maintenance of location (GO:0051235),163,31,14.68,+,2.11,3.43E-04,7.30E-03
positive regulation of innate immune response (GO:0045089),221,42,19.91,+,2.11,3.72E-05,1.03E-03
mRNA catabolic process (GO:0006402),216,41,19.46,+,2.11,4.96E-05,1.34E-03
negative regulation of cellular protein localization (GO:1903828),116,22,10.45,+,2.11,2.72E-03,4.15E-02
regulation of cellular catabolic process (GO:0031329),855,162,77.01,+,2.1,1.96E-16,2.52E-14
positive regulation of response to biotic stimulus (GO:0002833),259,49,23.33,+,2.1,8.82E-06,2.86E-04
negative regulation of protein kinase activity (GO:0006469),238,45,21.44,+,2.1,2.69E-05,7.70E-04
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),196,37,17.65,+,2.1,1.07E-04,2.63E-03
mRNA metabolic process (GO:0016071),694,131,62.51,+,2.1,2.41E-13,2.30E-11
cell cycle (GO:0007049),1390,262,125.2,+,2.09,3.99E-26,1.43E-23
positive regulation of programmed cell death (GO:0043068),564,106,50.8,+,2.09,7.43E-11,5.47E-09
cell cycle process (GO:0022402),1070,201,96.38,+,2.09,7.97E-20,1.53E-17
regulation of response to DNA damage stimulus (GO:2001020),224,42,20.18,+,2.08,4.40E-05,1.20E-03
macroautophagy (GO:0016236),192,36,17.29,+,2.08,1.50E-04,3.54E-03
negative regulation of protein catabolic process (GO:0042177),123,23,11.08,+,2.08,2.33E-03,3.71E-02
peptidyl-serine phosphorylation (GO:0018105),182,34,16.39,+,2.07,2.58E-04,5.70E-03
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),134,25,12.07,+,2.07,1.99E-03,3.24E-02
epithelial cell development (GO:0002064),193,36,17.38,+,2.07,2.34E-04,5.27E-03
endomembrane system organization (GO:0010256),488,91,43.95,+,2.07,2.30E-09,1.37E-07
regulation of protein dephosphorylation (GO:0035304),145,27,13.06,+,2.07,1.17E-03,2.09E-02
regulation of protein binding (GO:0043393),199,37,17.92,+,2.06,1.79E-04,4.13E-03
nuclear division (GO:0000280),340,63,30.62,+,2.06,9.07E-07,3.63E-05
cilium assembly (GO:0060271),378,70,34.05,+,2.06,2.15E-07,9.70E-06
positive regulation of cell death (GO:0010942),627,116,56.47,+,2.05,2.55E-11,1.97E-09
regulation of translation (GO:0006417),368,68,33.15,+,2.05,3.74E-07,1.63E-05
protein phosphorylation (GO:0006468),684,126,61.61,+,2.05,2.98E-12,2.62E-10
intracellular signal transduction (GO:0035556),1575,289,141.86,+,2.04,3.50E-27,1.35E-24
regulation of response to cytokine stimulus (GO:0060759),175,32,15.76,+,2.03,5.29E-04,1.05E-02
regulation of innate immune response (GO:0045088),312,57,28.1,+,2.03,5.45E-06,1.87E-04
regulation of endocytosis (GO:0030100),208,38,18.73,+,2.03,1.64E-04,3.82E-03
negative regulation of catabolic process (GO:0009895),313,57,28.19,+,2.02,5.60E-06,1.91E-04
translational initiation (GO:0006413),143,26,12.88,+,2.02,1.83E-03,3.04E-02
regulation of anatomical structure size (GO:0090066),506,92,45.58,+,2.02,6.54E-09,3.71E-07
negative regulation of canonical Wnt signaling pathway (GO:0090090),182,33,16.39,+,2.01,6.41E-04,1.25E-02
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),243,44,21.89,+,2.01,8.08E-05,2.08E-03
regulation of cellular response to stress (GO:0080135),685,124,61.7,+,2.01,1.75E-11,1.42E-09
regulation of peptidyl-serine phosphorylation (GO:0033135),144,26,12.97,+,2,1.94E-03,3.18E-02
regulation of plasma membrane bounded cell projection organization (GO:0120035),621,112,55.93,+,2,2.00E-10,1.40E-08
negative regulation of kinase activity (GO:0033673),261,47,23.51,+,2,3.94E-05,1.08E-03
positive regulation of epithelial cell migration (GO:0010634),150,27,13.51,+,2,2.18E-03,3.50E-02
negative regulation of DNA metabolic process (GO:0051053),139,25,12.52,+,2,2.54E-03,3.96E-02
organelle organization (GO:0006996),3574,642,321.91,+,1.99,1.99E-64,3.14E-60
protein localization to cell periphery (GO:1990778),234,42,21.08,+,1.99,1.03E-04,2.56E-03
DNA repair (GO:0006281),530,95,47.74,+,1.99,5.89E-09,3.37E-07
cellular response to insulin stimulus (GO:0032869),173,31,15.58,+,1.99,1.19E-03,2.12E-02
cellular response to DNA damage stimulus (GO:0006974),787,141,70.89,+,1.99,8.82E-13,8.19E-11
cilium organization (GO:0044782),402,72,36.21,+,1.99,4.66E-07,2.00E-05
regulation of cell cycle (GO:0051726),1196,214,107.72,+,1.99,5.41E-19,9.27E-17
DNA conformation change (GO:0071103),313,56,28.19,+,1.99,8.99E-06,2.90E-04
response to UV (GO:0009411),151,27,13.6,+,1.99,2.26E-03,3.61E-02
regulation of cell projection organization (GO:0031344),638,114,57.46,+,1.98,2.18E-10,1.51E-08
organelle fission (GO:0048285),370,66,33.33,+,1.98,1.57E-06,5.93E-05
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),185,33,16.66,+,1.98,7.13E-04,1.37E-02
chromosome segregation (GO:0007059),286,51,25.76,+,1.98,2.32E-05,6.79E-04
negative regulation of cellular component organization (GO:0051129),718,128,64.67,+,1.98,1.99E-11,1.57E-09
double-strand break repair (GO:0006302),202,36,18.19,+,1.98,4.97E-04,1.01E-02
regulation of hydrolase activity (GO:0051336),1308,233,117.81,+,1.98,2.63E-20,5.31E-18
negative regulation of binding (GO:0051100),163,29,14.68,+,1.98,1.41E-03,2.44E-02
negative regulation of cellular catabolic process (GO:0031330),253,45,22.79,+,1.97,7.45E-05,1.93E-03
myeloid cell differentiation (GO:0030099),225,40,20.27,+,1.97,1.84E-04,4.22E-03
regulation of carbohydrate metabolic process (GO:0006109),214,38,19.28,+,1.97,3.01E-04,6.52E-03
negative regulation of Wnt signaling pathway (GO:0030178),214,38,19.28,+,1.97,3.01E-04,6.51E-03
response to insulin (GO:0032868),237,42,21.35,+,1.97,1.62E-04,3.79E-03
positive regulation of cellular catabolic process (GO:0031331),390,69,35.13,+,1.96,1.20E-06,4.70E-05
tube formation (GO:0035148),147,26,13.24,+,1.96,3.12E-03,4.67E-02
intrinsic apoptotic signaling pathway (GO:0097193),147,26,13.24,+,1.96,3.12E-03,4.67E-02
regulation of cellular component organization (GO:0051128),2360,417,212.57,+,1.96,5.46E-37,5.06E-34
autophagy (GO:0006914),306,54,27.56,+,1.96,1.77E-05,5.34E-04
process utilizing autophagic mechanism (GO:0061919),306,54,27.56,+,1.96,1.77E-05,5.33E-04
regulation of response to biotic stimulus (GO:0002831),421,74,37.92,+,1.95,5.57E-07,2.33E-05
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),165,29,14.86,+,1.95,2.25E-03,3.60E-02
intracellular protein transport (GO:0006886),973,171,87.64,+,1.95,1.35E-14,1.43E-12
positive regulation of cellular protein catabolic process (GO:1903364),154,27,13.87,+,1.95,2.56E-03,3.97E-02
cellular response to radiation (GO:0071478),177,31,15.94,+,1.94,1.35E-03,2.35E-02
biological process involved in interaction with host (GO:0051701),177,31,15.94,+,1.94,1.35E-03,2.35E-02
blood coagulation (GO:0007596),298,52,26.84,+,1.94,3.30E-05,9.27E-04
lymphocyte activation (GO:0046649),391,68,35.22,+,1.93,2.83E-06,1.01E-04
cell junction organization (GO:0034330),501,87,45.13,+,1.93,1.16E-07,5.50E-06
regulation of cell junction assembly (GO:1901888),196,34,17.65,+,1.93,9.87E-04,1.82E-02
coagulation (GO:0050817),300,52,27.02,+,1.92,5.12E-05,1.37E-03
regulation of DNA-binding transcription factor activity (GO:0051090),433,75,39,+,1.92,7.78E-07,3.18E-05
regulation of establishment of protein localization (GO:0070201),592,102,53.32,+,1.91,9.82E-09,5.42E-07
protein transport (GO:0015031),1463,252,131.77,+,1.91,2.50E-20,5.11E-18
hemostasis (GO:0007599),302,52,27.2,+,1.91,5.38E-05,1.43E-03
cell-cell signaling by wnt (GO:0198738),349,60,31.43,+,1.91,1.63E-05,4.98E-04
Wnt signaling pathway (GO:0016055),349,60,31.43,+,1.91,1.63E-05,4.97E-04
positive regulation of catabolic process (GO:0009896),460,79,41.43,+,1.91,6.81E-07,2.80E-05
establishment of localization in cell (GO:0051649),2365,405,213.02,+,1.9,4.06E-33,3.20E-30
negative regulation of protein phosphorylation (GO:0001933),351,60,31.61,+,1.9,1.71E-05,5.20E-04
regulation of cytokine-mediated signaling pathway (GO:0001959),164,28,14.77,+,1.9,3.35E-03,4.90E-02
RNA catabolic process (GO:0006401),246,42,22.16,+,1.9,3.22E-04,6.89E-03
protein localization (GO:0008104),2158,368,194.37,+,1.89,1.33E-29,6.38E-27
positive regulation of nucleobase-containing compound metabolic process (GO:0045935),1891,322,170.32,+,1.89,1.49E-25,4.79E-23
peptide transport (GO:0015833),1492,254,134.39,+,1.89,5.61E-20,1.09E-17
cellular protein localization (GO:0034613),1639,279,147.63,+,1.89,7.23E-22,1.81E-19
cellular macromolecule localization (GO:0070727),1645,280,148.17,+,1.89,5.53E-22,1.41E-19
regulation of canonical Wnt signaling pathway (GO:0060828),288,49,25.94,+,1.89,1.27E-04,3.05E-03
cell projection organization (GO:0030030),1212,206,109.17,+,1.89,4.90E-16,6.19E-14
peptidyl-serine modification (GO:0018209),206,35,18.55,+,1.89,1.30E-03,2.28E-02
regulation of intracellular signal transduction (GO:1902531),1768,300,159.24,+,1.88,2.10E-23,5.52E-21
negative regulation of phosphorylation (GO:0042326),395,67,35.58,+,1.88,7.11E-06,2.37E-04
regulation of autophagy (GO:0010506),331,56,29.81,+,1.88,3.58E-05,9.97E-04
plasma membrane bounded cell projection organization (GO:0120036),1166,197,105.02,+,1.88,4.10E-15,4.55E-13
protein-containing complex disassembly (GO:0032984),225,38,20.27,+,1.88,6.60E-04,1.28E-02
regulation of cysteine-type endopeptidase activity (GO:2000116),237,40,21.35,+,1.87,5.72E-04,1.13E-02
regulation of cellular protein catabolic process (GO:1903362),255,43,22.97,+,1.87,4.06E-04,8.41E-03
viral gene expression (GO:0019080),172,29,15.49,+,1.87,2.88E-03,4.38E-02
antigen processing and presentation of exogenous peptide antigen (GO:0002478),178,30,16.03,+,1.87,3.21E-03,4.75E-02
regulation of proteasomal protein catabolic process (GO:0061136),184,31,16.57,+,1.87,2.49E-03,3.90E-02
leukocyte degranulation (GO:0043299),506,85,45.58,+,1.87,4.55E-07,1.96E-05
cellular response to peptide hormone stimulus (GO:0071375),274,46,24.68,+,1.86,2.07E-04,4.69E-03
negative regulation of phosphate metabolic process (GO:0045936),513,86,46.21,+,1.86,5.24E-07,2.21E-05
regulation of protein transport (GO:0051223),567,95,51.07,+,1.86,1.25E-07,5.86E-06
cellular localization (GO:0051641),3003,503,270.48,+,1.86,3.80E-40,4.61E-37
homeostasis of number of cells (GO:0048872),215,36,19.37,+,1.86,1.12E-03,2.02E-02
nuclear chromosome segregation (GO:0098813),227,38,20.45,+,1.86,9.90E-04,1.82E-02
cellular component assembly (GO:0022607),2438,408,219.59,+,1.86,1.47E-31,8.61E-29
negative regulation of phosphorus metabolic process (GO:0010563),514,86,46.3,+,1.86,5.36E-07,2.25E-05
leukocyte differentiation (GO:0002521),353,59,31.79,+,1.86,3.99E-05,1.10E-03
amide transport (GO:0042886),1526,255,137.45,+,1.86,4.27E-19,7.48E-17
negative regulation of gene expression (GO:0010629),964,161,86.83,+,1.85,3.42E-12,2.93E-10
myeloid leukocyte mediated immunity (GO:0002444),515,86,46.39,+,1.85,5.50E-07,2.31E-05
establishment of protein localization (GO:0045184),1558,260,140.33,+,1.85,2.62E-19,4.64E-17
positive regulation of growth (GO:0045927),258,43,23.24,+,1.85,4.38E-04,8.96E-03
antigen processing and presentation of exogenous antigen (GO:0019884),186,31,16.75,+,1.85,2.66E-03,4.08E-02
positive regulation of molecular function (GO:0044093),1766,294,159.06,+,1.85,8.41E-22,2.07E-19
MAPK cascade (GO:0000165),409,68,36.84,+,1.85,1.01E-05,3.20E-04
regulation of protein catabolic process (GO:0042176),397,66,35.76,+,1.85,1.17E-05,3.70E-04
negative regulation of transferase activity (GO:0051348),301,50,27.11,+,1.84,1.74E-04,4.04E-03
DNA replication (GO:0006260),271,45,24.41,+,1.84,4.05E-04,8.40E-03
positive regulation of protein catabolic process (GO:0045732),235,39,21.17,+,1.84,8.25E-04,1.56E-02
antigen processing and presentation (GO:0019882),223,37,20.09,+,1.84,1.33E-03,2.32E-02
regulation of cell-substrate adhesion (GO:0010810),217,36,19.55,+,1.84,1.21E-03,2.15E-02
positive regulation of RNA metabolic process (GO:0051254),1718,285,154.74,+,1.84,5.11E-21,1.20E-18
negative regulation of protein modification process (GO:0031400),549,91,49.45,+,1.84,3.85E-07,1.67E-05
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),519,86,46.75,+,1.84,6.30E-07,2.61E-05
response to virus (GO:0009615),308,51,27.74,+,1.84,1.41E-04,3.37E-03
positive regulation of catalytic activity (GO:0043085),1415,234,127.45,+,1.84,4.54E-17,6.28E-15
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),212,35,19.09,+,1.83,1.57E-03,2.65E-02
regulation of peptide transport (GO:0090087),600,99,54.04,+,1.83,1.25E-07,5.87E-06
positive regulation of macromolecule biosynthetic process (GO:0010557),1853,305,166.9,+,1.83,5.29E-22,1.37E-19
regulation of epithelial cell migration (GO:0010632),231,38,20.81,+,1.83,1.11E-03,2.01E-02
regulation of cellular amide metabolic process (GO:0034248),432,71,38.91,+,1.82,8.17E-06,2.69E-04
neutrophil mediated immunity (GO:0002446),493,81,44.4,+,1.82,2.23E-06,8.11E-05
negative regulation of cell cycle process (GO:0010948),335,55,30.17,+,1.82,8.66E-05,2.21E-03
cell cycle checkpoint (GO:0000075),189,31,17.02,+,1.82,3.01E-03,4.54E-02
regulation of binding (GO:0051098),366,60,32.97,+,1.82,5.38E-05,1.43E-03
regulation of Wnt signaling pathway (GO:0030111),366,60,32.97,+,1.82,5.38E-05,1.43E-03
positive regulation of cell-cell adhesion (GO:0022409),281,46,25.31,+,1.82,3.57E-04,7.55E-03
positive regulation of nucleic acid-templated transcription (GO:1903508),1622,265,146.09,+,1.81,1.10E-18,1.83E-16
"positive regulation of transcription, DNA-templated (GO:0045893)",1622,265,146.09,+,1.81,1.10E-18,1.81E-16
regulation of anatomical structure morphogenesis (GO:0022603),955,156,86.02,+,1.81,4.06E-11,3.08E-09
positive regulation of anion transport (GO:1903793),502,82,45.22,+,1.81,1.94E-06,7.14E-05
positive regulation of RNA biosynthetic process (GO:1902680),1623,265,146.18,+,1.81,1.14E-18,1.85E-16
intracellular receptor signaling pathway (GO:0030522),196,32,17.65,+,1.81,3.35E-03,4.89E-02
cell morphogenesis (GO:0000902),711,116,64.04,+,1.81,1.59E-08,8.56E-07
positive regulation of neurogenesis (GO:0050769),221,36,19.91,+,1.81,1.88E-03,3.10E-02
"transcription, DNA-templated (GO:0006351)",553,90,49.81,+,1.81,8.87E-07,3.57E-05
cell morphogenesis involved in neuron differentiation (GO:0048667),449,73,40.44,+,1.81,8.30E-06,2.72E-04
transcription by RNA polymerase II (GO:0006366),406,66,36.57,+,1.8,2.91E-05,8.26E-04
cellular component biogenesis (GO:0044085),2701,439,243.28,+,1.8,1.31E-31,8.61E-29
regulation of protein modification by small protein conjugation or removal (GO:1903320),240,39,21.62,+,1.8,1.34E-03,2.34E-02
nucleic acid-templated transcription (GO:0097659),554,90,49.9,+,1.8,9.04E-07,3.63E-05
granulocyte activation (GO:0036230),499,81,44.95,+,1.8,2.69E-06,9.67E-05
negative regulation of macromolecule biosynthetic process (GO:0010558),1498,243,134.93,+,1.8,8.35E-17,1.13E-14
regulation of vesicle-mediated transport (GO:0060627),524,85,47.2,+,1.8,2.09E-06,7.64E-05
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1487,241,133.93,+,1.8,1.40E-16,1.82E-14
negative regulation of transcription by RNA polymerase II (GO:0000122),902,146,81.24,+,1.8,2.67E-10,1.80E-08
neutrophil degranulation (GO:0043312),482,78,43.41,+,1.8,5.37E-06,1.84E-04
cellular response to peptide (GO:1901653),334,54,30.08,+,1.8,1.72E-04,4.00E-03
neutrophil activation (GO:0042119),495,80,44.58,+,1.79,3.59E-06,1.26E-04
regulation of catalytic activity (GO:0050790),2516,404,226.62,+,1.78,8.90E-28,3.79E-25
neutrophil activation involved in immune response (GO:0002283),486,78,43.77,+,1.78,6.10E-06,2.06E-04
myeloid cell activation involved in immune response (GO:0002275),524,84,47.2,+,1.78,3.03E-06,1.07E-04
membrane organization (GO:0061024),956,153,86.11,+,1.78,1.89E-10,1.34E-08
wound healing (GO:0042060),444,71,39.99,+,1.78,2.15E-05,6.35E-04
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),219,35,19.73,+,1.77,2.67E-03,4.09E-02
negative regulation of RNA metabolic process (GO:0051253),1394,222,125.56,+,1.77,1.27E-14,1.35E-12
hemopoiesis (GO:0030097),572,91,51.52,+,1.77,1.38E-06,5.30E-05
RNA biosynthetic process (GO:0032774),566,90,50.98,+,1.77,1.70E-06,6.41E-05
positive regulation of cellular biosynthetic process (GO:0031328),1956,311,176.18,+,1.77,2.08E-20,4.38E-18
regulation of programmed cell death (GO:0043067),1517,241,136.64,+,1.76,1.13E-15,1.38E-13
cell morphogenesis involved in differentiation (GO:0000904),554,88,49.9,+,1.76,2.67E-06,9.63E-05
positive regulation of cell cycle process (GO:0090068),296,47,26.66,+,1.76,6.94E-04,1.33E-02
cellular response to abiotic stimulus (GO:0071214),315,50,28.37,+,1.76,3.65E-04,7.68E-03
cellular response to environmental stimulus (GO:0104004),315,50,28.37,+,1.76,3.65E-04,7.67E-03
immune response-activating cell surface receptor signaling pathway (GO:0002429),454,72,40.89,+,1.76,2.63E-05,7.59E-04
negative regulation of apoptotic signaling pathway (GO:2001234),227,36,20.45,+,1.76,3.09E-03,4.64E-02
immune response-activating signal transduction (GO:0002757),454,72,40.89,+,1.76,2.63E-05,7.57E-04
negative regulation of intracellular signal transduction (GO:1902532),492,78,44.31,+,1.76,9.62E-06,3.08E-04
phosphorylation (GO:0016310),1022,162,92.05,+,1.76,1.10E-10,7.99E-09
macromolecule localization (GO:0033036),2550,404,229.68,+,1.76,8.40E-27,3.15E-24
positive regulation of transcription by RNA polymerase II (GO:0045944),1206,191,108.62,+,1.76,2.01E-12,1.79E-10
positive regulation of cell migration (GO:0030335),518,82,46.66,+,1.76,5.65E-06,1.92E-04
regulation of apoptotic process (GO:0042981),1479,234,133.21,+,1.76,4.88E-15,5.31E-13
negative regulation of nucleobase-containing compound metabolic process (GO:0045934),1514,239,136.37,+,1.75,2.33E-15,2.62E-13
positive regulation of biosynthetic process (GO:0009891),1990,314,179.24,+,1.75,3.93E-20,7.75E-18
regulation of neuron projection development (GO:0010975),438,69,39.45,+,1.75,3.94E-05,1.08E-03
negative regulation of cellular biosynthetic process (GO:0031327),1556,245,140.15,+,1.75,1.63E-15,1.93E-13
lymphocyte differentiation (GO:0030098),248,39,22.34,+,1.75,2.29E-03,3.66E-02
microtubule-based movement (GO:0007018),350,55,31.52,+,1.74,2.46E-04,5.47E-03
cell projection morphogenesis (GO:0048858),503,79,45.31,+,1.74,1.18E-05,3.71E-04
regulation of cell adhesion (GO:0030155),726,114,65.39,+,1.74,1.29E-07,6.06E-06
activation of immune response (GO:0002253),529,83,47.65,+,1.74,6.89E-06,2.31E-04
negative regulation of biosynthetic process (GO:0009890),1588,249,143.03,+,1.74,1.43E-15,1.72E-13
mononuclear cell differentiation (GO:1903131),287,45,25.85,+,1.74,1.18E-03,2.11E-02
vesicle-mediated transport (GO:0016192),1958,307,176.36,+,1.74,2.11E-19,3.78E-17
regulation of myeloid cell differentiation (GO:0045637),236,37,21.26,+,1.74,2.67E-03,4.08E-02
protein localization to organelle (GO:0033365),791,124,71.25,+,1.74,3.80E-08,1.98E-06
hematopoietic or lymphoid organ development (GO:0048534),619,97,55.75,+,1.74,1.16E-06,4.60E-05
nitrogen compound transport (GO:0071705),1801,282,162.22,+,1.74,1.19E-17,1.72E-15
plasma membrane bounded cell projection morphogenesis (GO:0120039),499,78,44.95,+,1.74,1.55E-05,4.75E-04
positive regulation of cell cycle (GO:0045787),391,61,35.22,+,1.73,1.34E-04,3.20E-03
cell activation (GO:0001775),1084,169,97.64,+,1.73,1.22E-10,8.86E-09
regulated exocytosis (GO:0045055),693,108,62.42,+,1.73,3.96E-07,1.71E-05
apoptotic signaling pathway (GO:0097190),276,43,24.86,+,1.73,1.39E-03,2.41E-02
epithelial tube morphogenesis (GO:0060562),302,47,27.2,+,1.73,8.16E-04,1.55E-02
immune system development (GO:0002520),656,102,59.09,+,1.73,8.23E-07,3.34E-05
negative regulation of cellular protein metabolic process (GO:0032269),984,153,88.63,+,1.73,1.27E-09,7.82E-08
exocytosis (GO:0006887),785,122,70.71,+,1.73,6.89E-08,3.40E-06
"negative regulation of transcription, DNA-templated (GO:0045892)",1288,200,116.01,+,1.72,3.08E-12,2.68E-10
negative regulation of nucleic acid-templated transcription (GO:1903507),1290,200,116.19,+,1.72,3.20E-12,2.78E-10
cellular component disassembly (GO:0022411),400,62,36.03,+,1.72,1.53E-04,3.61E-03
regulation of molecular function (GO:0065009),3178,492,286.24,+,1.72,2.39E-31,1.35E-28
negative regulation of RNA biosynthetic process (GO:1902679),1292,200,116.37,+,1.72,3.37E-12,2.91E-10
immune response-regulating cell surface receptor signaling pathway (GO:0002768),491,76,44.22,+,1.72,2.66E-05,7.65E-04
positive regulation of cell motility (GO:2000147),543,84,48.91,+,1.72,1.22E-05,3.80E-04
positive regulation of cellular component movement (GO:0051272),556,86,50.08,+,1.72,7.92E-06,2.62E-04
RNA metabolic process (GO:0016070),1599,247,144.02,+,1.72,7.21E-15,7.79E-13
synapse organization (GO:0050808),285,44,25.67,+,1.71,1.61E-03,2.72E-02
regulation of cell death (GO:0010941),1652,255,148.8,+,1.71,3.06E-15,3.42E-13
positive regulation of locomotion (GO:0040017),558,86,50.26,+,1.71,8.40E-06,2.75E-04
positive regulation of cell adhesion (GO:0045785),435,67,39.18,+,1.71,1.03E-04,2.57E-03
leukocyte activation (GO:0045321),935,144,84.22,+,1.71,8.07E-09,4.53E-07
RNA processing (GO:0006396),923,142,83.13,+,1.71,9.38E-09,5.19E-07
immune response-regulating signaling pathway (GO:0002764),494,76,44.49,+,1.71,3.86E-05,1.06E-03
nucleic acid metabolic process (GO:0090304),2232,343,201.04,+,1.71,1.70E-20,3.62E-18
DNA metabolic process (GO:0006259),781,120,70.34,+,1.71,1.73E-07,7.93E-06
axonogenesis (GO:0007409),384,59,34.59,+,1.71,3.16E-04,6.77E-03
positive regulation of cellular metabolic process (GO:0031325),3238,496,291.65,+,1.7,1.35E-30,7.08E-28
protein-DNA complex subunit organization (GO:0071824),294,45,26.48,+,1.7,1.41E-03,2.44E-02
cell activation involved in immune response (GO:0002263),634,97,57.1,+,1.7,2.97E-06,1.05E-04
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114),419,64,37.74,+,1.7,1.57E-04,3.69E-03
regulation of hemopoiesis (GO:1903706),393,60,35.4,+,1.7,2.69E-04,5.90E-03
response to peptide hormone (GO:0043434),400,61,36.03,+,1.69,2.98E-04,6.46E-03
positive regulation of nitrogen compound metabolic process (GO:0051173),3058,466,275.44,+,1.69,6.00E-28,2.63E-25
cellular response to stress (GO:0033554),1755,267,158.07,+,1.69,2.22E-15,2.55E-13
response to peptide (GO:1901652),480,73,43.23,+,1.69,6.11E-05,1.61E-03
nucleobase-containing compound catabolic process (GO:0034655),375,57,33.78,+,1.69,3.95E-04,8.20E-03
regulation of signal transduction (GO:0009966),3047,463,274.44,+,1.69,1.54E-27,6.39E-25
negative regulation of nitrogen compound metabolic process (GO:0051172),2390,363,215.27,+,1.69,6.14E-21,1.42E-18
positive regulation of macromolecule metabolic process (GO:0010604),3431,521,309.03,+,1.69,1.44E-31,8.73E-29
neuron projection morphogenesis (GO:0048812),495,75,44.58,+,1.68,5.58E-05,1.48E-03
negative regulation of protein metabolic process (GO:0051248),1056,160,95.11,+,1.68,2.98E-09,1.74E-07
cell part morphogenesis (GO:0032990),522,79,47.02,+,1.68,4.42E-05,1.21E-03
regulation of protein modification process (GO:0031399),1633,247,147.08,+,1.68,6.71E-14,6.78E-12
morphogenesis of an epithelium (GO:0002009),430,65,38.73,+,1.68,1.88E-04,4.29E-03
negative regulation of macromolecule metabolic process (GO:0010605),2861,432,257.69,+,1.68,5.43E-25,1.68E-22
regulation of developmental growth (GO:0048638),318,48,28.64,+,1.68,1.47E-03,2.51E-02
peptidyl-amino acid modification (GO:0018193),875,132,78.81,+,1.67,1.12E-07,5.33E-06
regulation of phosphate metabolic process (GO:0019220),1611,243,145.1,+,1.67,1.31E-13,1.28E-11
regulation of phosphorus metabolic process (GO:0051174),1611,243,145.1,+,1.67,1.31E-13,1.28E-11
neuron projection development (GO:0031175),683,103,61.52,+,1.67,2.52E-06,9.11E-05
leukocyte activation involved in immune response (GO:0002366),630,95,56.74,+,1.67,7.21E-06,2.40E-04
regulation of neurogenesis (GO:0050767),352,53,31.7,+,1.67,9.55E-04,1.77E-02
ribonucleoprotein complex biogenesis (GO:0022613),465,70,41.88,+,1.67,1.24E-04,3.00E-03
protein-containing complex subunit organization (GO:0043933),1581,238,142.4,+,1.67,3.07E-13,2.90E-11
enzyme linked receptor protein signaling pathway (GO:0007167),726,109,65.39,+,1.67,1.82E-06,6.77E-05
cellular component organization (GO:0016043),5775,866,520.16,+,1.66,2.81E-59,1.48E-55
myeloid leukocyte activation (GO:0002274),587,88,52.87,+,1.66,1.83E-05,5.49E-04
regulation of kinase activity (GO:0043549),908,136,81.78,+,1.66,9.74E-08,4.74E-06
negative regulation of mitotic cell cycle (GO:0045930),294,44,26.48,+,1.66,2.65E-03,4.08E-02
negative regulation of cell cycle (GO:0045786),569,85,51.25,+,1.66,2.68E-05,7.68E-04
regulation of phosphorylation (GO:0042325),1400,209,126.1,+,1.66,2.55E-11,1.98E-09
apoptotic process (GO:0006915),912,136,82.14,+,1.66,1.05E-07,5.08E-06
cellular component morphogenesis (GO:0032989),604,90,54.4,+,1.65,1.75E-05,5.29E-04
negative regulation of signal transduction (GO:0009968),1276,190,114.93,+,1.65,2.60E-10,1.76E-08
regulation of MAP kinase activity (GO:0043405),309,46,27.83,+,1.65,2.42E-03,3.83E-02
modification-dependent macromolecule catabolic process (GO:0043632),551,82,49.63,+,1.65,5.03E-05,1.36E-03
positive regulation of protein serine/threonine kinase activity (GO:0071902),316,47,28.46,+,1.65,2.00E-03,3.25E-02
biological process involved in interspecies interaction between organisms (GO:0044419),2118,315,190.77,+,1.65,6.24E-17,8.49E-15
positive regulation of metabolic process (GO:0009893),3719,553,334.97,+,1.65,1.13E-31,7.74E-29
regulation of cell growth (GO:0001558),417,62,37.56,+,1.65,3.98E-04,8.26E-03
positive regulation of proteolysis (GO:0045862),370,55,33.33,+,1.65,9.24E-04,1.72E-02
protein modification by small protein conjugation or removal (GO:0070647),1031,153,92.86,+,1.65,1.95E-08,1.04E-06
regulation of transferase activity (GO:0051338),1025,152,92.32,+,1.65,2.40E-08,1.26E-06
ubiquitin-dependent protein catabolic process (GO:0006511),533,79,48.01,+,1.65,7.23E-05,1.88E-03
cellular component organization or biogenesis (GO:0071840),5999,889,540.33,+,1.65,2.30E-59,1.81E-55
modification-dependent protein catabolic process (GO:0019941),540,80,48.64,+,1.64,6.04E-05,1.60E-03
axon development (GO:0061564),419,62,37.74,+,1.64,5.49E-04,1.09E-02
regulation of neuron death (GO:1901214),311,46,28.01,+,1.64,2.53E-03,3.94E-02
negative regulation of cellular metabolic process (GO:0031324),2580,381,232.38,+,1.64,3.56E-20,7.12E-18
negative regulation of catalytic activity (GO:0043086),814,120,73.32,+,1.64,1.05E-06,4.17E-05
response to wounding (GO:0009611),543,80,48.91,+,1.64,8.29E-05,2.13E-03
cellular response to hormone stimulus (GO:0032870),523,77,47.11,+,1.63,1.15E-04,2.79E-03
positive regulation of response to external stimulus (GO:0032103),503,74,45.31,+,1.63,1.59E-04,3.72E-03
protein localization to membrane (GO:0072657),537,79,48.37,+,1.63,1.03E-04,2.56E-03
regulation of protein serine/threonine kinase activity (GO:0071900),490,72,44.13,+,1.63,1.83E-04,4.21E-03
negative regulation of metabolic process (GO:0009892),3104,455,279.58,+,1.63,5.69E-24,1.58E-21
positive regulation of transport (GO:0051050),936,137,84.31,+,1.63,2.69E-07,1.20E-05
cellular response to external stimulus (GO:0071496),342,50,30.8,+,1.62,2.13E-03,3.43E-02
nucleobase-containing compound metabolic process (GO:0006139),2719,397,244.9,+,1.62,2.31E-20,4.80E-18
cellular response to nitrogen compound (GO:1901699),651,95,58.64,+,1.62,2.46E-05,7.15E-04
protein-containing complex assembly (GO:0065003),1337,195,120.42,+,1.62,6.15E-10,4.06E-08
cellular macromolecule catabolic process (GO:0044265),912,133,82.14,+,1.62,4.79E-07,2.04E-05
regulation of nucleobase-containing compound metabolic process (GO:0019219),4007,584,360.91,+,1.62,1.35E-31,8.54E-29
regulation of cellular protein metabolic process (GO:0032268),2437,355,219.5,+,1.62,7.03E-18,1.04E-15
regulation of protein kinase activity (GO:0045859),797,116,71.79,+,1.62,2.78E-06,9.96E-05
neuron development (GO:0048666),833,121,75.03,+,1.61,1.83E-06,6.81E-05
regulation of cellular component movement (GO:0051270),1026,149,92.41,+,1.61,1.10E-07,5.30E-06
negative regulation of molecular function (GO:0044092),1171,170,105.47,+,1.61,1.17E-08,6.32E-07
negative regulation of cell communication (GO:0010648),1373,199,123.67,+,1.61,7.12E-10,4.64E-08
regulation of signaling (GO:0023051),3459,501,311.55,+,1.61,8.42E-26,2.82E-23
programmed cell death (GO:0012501),1044,151,94.03,+,1.61,1.06E-07,5.09E-06
negative regulation of signaling (GO:0023057),1376,199,123.94,+,1.61,7.53E-10,4.88E-08
regulation of T cell activation (GO:0050863),332,48,29.9,+,1.61,3.38E-03,4.93E-02
macromolecule catabolic process (GO:0009057),1046,151,94.21,+,1.6,1.42E-07,6.60E-06
regulation of cell communication (GO:0010646),3424,494,308.4,+,1.6,5.51E-25,1.67E-22
regulation of anion transport (GO:0044070),860,124,77.46,+,1.6,1.93E-06,7.12E-05
positive regulation of defense response (GO:0031349),354,51,31.88,+,1.6,2.52E-03,3.93E-02
regulation of RNA metabolic process (GO:0051252),3738,538,336.68,+,1.6,1.98E-27,8.01E-25
positive regulation of ion transport (GO:0043270),709,102,63.86,+,1.6,2.17E-05,6.39E-04
nucleobase-containing compound biosynthetic process (GO:0034654),1003,144,90.34,+,1.59,3.54E-07,1.55E-05
heterocycle catabolic process (GO:0046700),418,60,37.65,+,1.59,1.33E-03,2.31E-02
regulation of growth (GO:0040008),657,94,59.18,+,1.59,4.83E-05,1.31E-03
regulation of protein metabolic process (GO:0051246),2595,371,233.73,+,1.59,1.41E-17,2.02E-15
regulation of cell development (GO:0060284),490,70,44.13,+,1.59,5.83E-04,1.15E-02
regulation of cell-cell adhesion (GO:0022407),434,62,39.09,+,1.59,1.22E-03,2.16E-02
cell death (GO:0008219),1079,154,97.19,+,1.58,1.63E-07,7.51E-06
regulation of cell motility (GO:2000145),947,135,85.3,+,1.58,1.32E-06,5.11E-05
regulation of cell migration (GO:0030334),885,126,79.71,+,1.58,2.67E-06,9.63E-05
positive regulation of protein modification process (GO:0031401),1061,151,95.56,+,1.58,3.01E-07,1.34E-05
positive regulation of cellular protein metabolic process (GO:0032270),1456,207,131.14,+,1.58,1.13E-09,7.07E-08
cellular response to organonitrogen compound (GO:0071417),591,84,53.23,+,1.58,1.57E-04,3.68E-03
positive regulation of intracellular signal transduction (GO:1902533),1015,144,91.42,+,1.58,7.19E-07,2.95E-05
heart development (GO:0007507),508,72,45.76,+,1.57,5.46E-04,1.08E-02
response to radiation (GO:0009314),445,63,40.08,+,1.57,1.39E-03,2.41E-02
cellular nitrogen compound catabolic process (GO:0044270),424,60,38.19,+,1.57,1.47E-03,2.50E-02
positive regulation of cellular process (GO:0048522),5656,800,509.44,+,1.57,3.40E-43,5.96E-40
regulation of locomotion (GO:0040012),990,140,89.17,+,1.57,1.24E-06,4.84E-05
positive regulation of transferase activity (GO:0051347),687,97,61.88,+,1.57,6.82E-05,1.79E-03
positive regulation of protein metabolic process (GO:0051247),1538,217,138.53,+,1.57,8.93E-10,5.75E-08
regulation of developmental process (GO:0050793),2441,344,219.86,+,1.56,1.93E-15,2.25E-13
regulation of macromolecule biosynthetic process (GO:0010556),3944,555,355.24,+,1.56,2.84E-26,1.04E-23
regulation of cellular macromolecule biosynthetic process (GO:2000112),3913,550,352.45,+,1.56,7.38E-26,2.53E-23
heterocycle metabolic process (GO:0046483),2904,407,261.56,+,1.56,4.58E-18,6.88E-16
positive regulation of signal transduction (GO:0009967),1551,217,139.7,+,1.55,1.80E-09,1.09E-07
positive regulation of kinase activity (GO:0033674),608,85,54.76,+,1.55,2.50E-04,5.54E-03
regulation of localization (GO:0032879),2734,382,246.25,+,1.55,1.18E-16,1.57E-14
response to cytokine (GO:0034097),1097,153,98.81,+,1.55,7.81E-07,3.19E-05
protein catabolic process (GO:0030163),683,95,61.52,+,1.54,1.14E-04,2.79E-03
positive regulation of cell differentiation (GO:0045597),827,115,74.49,+,1.54,2.13E-05,6.31E-04
positive regulation of gene expression (GO:0010628),1072,149,96.56,+,1.54,1.06E-06,4.20E-05
regulation of gene expression (GO:0010468),4872,677,438.82,+,1.54,3.86E-32,2.90E-29
negative regulation of programmed cell death (GO:0043069),907,126,81.69,+,1.54,9.97E-06,3.18E-04
regulation of nitrogen compound metabolic process (GO:0051171),5688,789,512.32,+,1.54,2.14E-39,2.25E-36
gene expression (GO:0010467),2186,303,196.89,+,1.54,9.59E-13,8.85E-11
cellular protein-containing complex assembly (GO:0034622),859,119,77.37,+,1.54,1.76E-05,5.31E-04
negative regulation of apoptotic process (GO:0043066),888,123,79.98,+,1.54,1.39E-05,4.29E-04
heterocycle biosynthetic process (GO:0018130),1076,149,96.92,+,1.54,1.41E-06,5.39E-05
cellular aromatic compound metabolic process (GO:0006725),2948,408,265.53,+,1.54,3.11E-17,4.39E-15
regulation of macromolecule metabolic process (GO:0060255),6301,872,567.53,+,1.54,3.39E-45,1.07E-41
negative regulation of cellular process (GO:0048523),4909,679,442.16,+,1.54,1.07E-31,7.64E-29
organic substance transport (GO:0071702),2170,300,195.45,+,1.53,1.85E-12,1.67E-10
regulation of cellular metabolic process (GO:0031323),6106,844,549.97,+,1.53,7.53E-43,1.19E-39
positive regulation of immune response (GO:0050778),738,102,66.47,+,1.53,9.06E-05,2.31E-03
secretion by cell (GO:0032940),948,131,85.39,+,1.53,6.97E-06,2.33E-04
establishment of protein localization to organelle (GO:0072594),449,62,40.44,+,1.53,2.51E-03,3.91E-02
immune effector process (GO:0002252),1095,151,98.63,+,1.53,1.34E-06,5.16E-05
regulation of nervous system development (GO:0051960),428,59,38.55,+,1.53,3.42E-03,4.98E-02
regulation of response to stimulus (GO:0048583),4240,584,381.9,+,1.53,1.04E-25,3.43E-23
regulation of primary metabolic process (GO:0080090),5892,811,530.69,+,1.53,1.02E-39,1.15E-36
tissue morphogenesis (GO:0048729),532,73,47.92,+,1.52,1.22E-03,2.16E-02
aromatic compound biosynthetic process (GO:0019438),1086,149,97.82,+,1.52,2.07E-06,7.59E-05
regulation of protein phosphorylation (GO:0001932),1210,166,108.99,+,1.52,5.15E-07,2.18E-05
regulation of response to stress (GO:0080134),1546,212,139.25,+,1.52,1.13E-08,6.17E-07
cellular response to cytokine stimulus (GO:0071345),1007,138,90.7,+,1.52,5.75E-06,1.95E-04
endocytosis (GO:0006897),562,77,50.62,+,1.52,7.70E-04,1.47E-02
muscle structure development (GO:0061061),460,63,41.43,+,1.52,2.81E-03,4.28E-02
brain development (GO:0007420),745,102,67.1,+,1.52,1.26E-04,3.04E-03
regulation of cellular biosynthetic process (GO:0031326),4105,562,369.74,+,1.52,5.81E-24,1.58E-21
cellular protein catabolic process (GO:0044257),629,86,56.65,+,1.52,4.10E-04,8.45E-03
positive regulation of biological process (GO:0048518),6244,853,562.4,+,1.52,1.42E-41,2.03E-38
regulation of biosynthetic process (GO:0009889),4189,571,377.3,+,1.51,4.99E-24,1.41E-21
negative regulation of cell death (GO:0060548),998,136,89.89,+,1.51,8.80E-06,2.86E-04
proteolysis involved in cellular protein catabolic process (GO:0051603),596,81,53.68,+,1.51,8.19E-04,1.55E-02
head development (GO:0060322),788,107,70.98,+,1.51,1.14E-04,2.79E-03
regulation of body fluid levels (GO:0050878),494,67,44.49,+,1.51,2.35E-03,3.74E-02
"regulation of transcription, DNA-templated (GO:0006355)",3464,469,312,+,1.5,1.62E-18,2.58E-16
regulation of nucleic acid-templated transcription (GO:1903506),3465,469,312.09,+,1.5,1.65E-18,2.59E-16
response to growth factor (GO:0070848),532,72,47.92,+,1.5,1.59E-03,2.69E-02
protein modification by small protein conjugation (GO:0032446),821,111,73.95,+,1.5,9.41E-05,2.39E-03
regulation of RNA biosynthetic process (GO:2001141),3470,469,312.54,+,1.5,2.25E-18,3.52E-16
cytokine-mediated signaling pathway (GO:0019221),682,92,61.43,+,1.5,4.07E-04,8.42E-03
positive regulation of protein kinase activity (GO:0045860),534,72,48.1,+,1.5,1.65E-03,2.77E-02
export from cell (GO:0140352),996,134,89.71,+,1.49,1.83E-05,5.49E-04
cellular protein modification process (GO:0006464),3019,406,271.92,+,1.49,2.31E-15,2.64E-13
protein modification process (GO:0036211),3019,406,271.92,+,1.49,2.31E-15,2.62E-13
cellular response to endogenous stimulus (GO:0071495),1146,154,103.22,+,1.49,4.54E-06,1.57E-04
regulation of metabolic process (GO:0019222),6847,920,616.71,+,1.49,1.34E-43,3.02E-40
positive regulation of signaling (GO:0023056),1720,231,154.92,+,1.49,1.18E-08,6.36E-07
secretion (GO:0046903),1061,142,95.56,+,1.49,1.23E-05,3.82E-04
regulation of transcription by RNA polymerase II (GO:0006357),2586,346,232.92,+,1.49,1.11E-12,1.02E-10
regulation of multicellular organismal development (GO:2000026),1318,176,118.71,+,1.48,1.07E-06,4.26E-05
anion transport (GO:0006820),2287,305,205.99,+,1.48,5.72E-11,4.28E-09
cellular response to growth factor stimulus (GO:0071363),503,67,45.31,+,1.48,3.32E-03,4.87E-02
negative regulation of biological process (GO:0048519),5541,736,499.08,+,1.47,6.74E-30,3.32E-27
regulation of cell differentiation (GO:0045595),1576,209,141.95,+,1.47,1.45E-07,6.74E-06
regulation of transport (GO:0051049),1758,233,158.34,+,1.47,2.65E-08,1.39E-06
positive regulation of cell communication (GO:0010647),1714,227,154.38,+,1.47,4.90E-08,2.50E-06
cellular response to oxygen-containing compound (GO:1901701),1058,140,95.29,+,1.47,2.45E-05,7.12E-04
positive regulation of phosphorylation (GO:0042327),913,120,82.23,+,1.46,1.28E-04,3.09E-03
response to hormone (GO:0009725),807,106,72.69,+,1.46,3.55E-04,7.55E-03
organic cyclic compound metabolic process (GO:1901360),3190,419,287.32,+,1.46,2.00E-14,2.07E-12
macromolecule modification (GO:0043412),3240,425,291.83,+,1.46,1.68E-14,1.76E-12
cellular macromolecule metabolic process (GO:0044260),4963,650,447.02,+,1.45,7.34E-24,1.96E-21
response to nitrogen compound (GO:1901698),1085,142,97.73,+,1.45,3.78E-05,1.05E-03
positive regulation of response to stimulus (GO:0048584),2278,298,205.18,+,1.45,6.27E-10,4.12E-08
positive regulation of immune system process (GO:0002684),1053,137,94.84,+,1.44,6.02E-05,1.59E-03
response to endogenous stimulus (GO:0009719),1416,184,127.54,+,1.44,2.93E-06,1.04E-04
phosphate-containing compound metabolic process (GO:0006796),1906,247,171.67,+,1.44,5.06E-08,2.57E-06
regulation of proteolysis (GO:0030162),734,95,66.11,+,1.44,1.26E-03,2.21E-02
positive regulation of phosphorus metabolic process (GO:0010562),989,128,89.08,+,1.44,1.43E-04,3.42E-03
positive regulation of phosphate metabolic process (GO:0045937),989,128,89.08,+,1.44,1.43E-04,3.41E-03
response to organonitrogen compound (GO:0010243),997,129,89.8,+,1.44,1.51E-04,3.57E-03
neuron differentiation (GO:0030182),1028,133,92.59,+,1.44,9.84E-05,2.48E-03
response to abiotic stimulus (GO:0009628),1162,150,104.66,+,1.43,4.22E-05,1.15E-03
generation of neurons (GO:0048699),1249,161,112.5,+,1.43,2.06E-05,6.16E-04
cellular nitrogen compound metabolic process (GO:0034641),3407,439,306.87,+,1.43,6.82E-14,6.85E-12
movement of cell or subcellular component (GO:0006928),1591,205,143.3,+,1.43,1.30E-06,5.05E-05
regulation of cytokine production (GO:0001817),707,91,63.68,+,1.43,1.63E-03,2.75E-02
tube morphogenesis (GO:0035239),645,83,58.1,+,1.43,2.56E-03,3.98E-02
positive regulation of developmental process (GO:0051094),1259,162,113.4,+,1.43,2.20E-05,6.46E-04
neurogenesis (GO:0022008),1369,176,123.31,+,1.43,9.93E-06,3.18E-04
leukocyte mediated immunity (GO:0002443),755,97,68,+,1.43,1.18E-03,2.11E-02
phosphorus metabolic process (GO:0006793),1933,248,174.11,+,1.42,1.18E-07,5.59E-06
cellular response to organic substance (GO:0071310),2331,299,209.95,+,1.42,3.67E-09,2.11E-07
regulation of MAPK cascade (GO:0043408),694,89,62.51,+,1.42,2.29E-03,3.66E-02
cell development (GO:0048468),1615,207,145.46,+,1.42,1.54E-06,5.87E-05
positive regulation of protein phosphorylation (GO:0001934),828,106,74.58,+,1.42,8.13E-04,1.55E-02
cellular protein metabolic process (GO:0044267),3643,466,328.13,+,1.42,2.13E-14,2.19E-12
regulation of ion transport (GO:0043269),1337,170,120.42,+,1.41,2.39E-05,6.97E-04
protein ubiquitination (GO:0016567),741,94,66.74,+,1.41,2.06E-03,3.34E-02
circulatory system development (GO:0072359),853,108,76.83,+,1.41,9.69E-04,1.79E-02
organic cyclic compound biosynthetic process (GO:1901362),1222,154,110.07,+,1.4,9.56E-05,2.43E-03
negative regulation of response to stimulus (GO:0048585),1804,227,162.49,+,1.4,1.68E-06,6.35E-05
macromolecule metabolic process (GO:0043170),6193,778,557.81,+,1.39,5.88E-25,1.72E-22
nervous system development (GO:0007399),2189,274,197.16,+,1.39,1.52E-07,7.06E-06
regulation of biological quality (GO:0065008),4007,499,360.91,+,1.38,1.28E-13,1.27E-11
central nervous system development (GO:0007417),991,123,89.26,+,1.38,9.60E-04,1.78E-02
response to organic substance (GO:0010033),2995,371,269.76,+,1.38,1.12E-09,7.03E-08
cellular nitrogen compound biosynthetic process (GO:0044271),1575,195,141.86,+,1.37,2.75E-05,7.82E-04
positive regulation of multicellular organismal process (GO:0051240),1386,171,124.84,+,1.37,1.07E-04,2.63E-03
regulation of immune response (GO:0050776),1129,139,101.69,+,1.37,5.18E-04,1.03E-02
cell surface receptor signaling pathway (GO:0007166),2486,306,223.92,+,1.37,9.42E-08,4.61E-06
response to stress (GO:0006950),3634,447,327.32,+,1.37,2.39E-11,1.87E-09
localization (GO:0051179),5807,714,523.04,+,1.37,8.05E-20,1.53E-17
establishment of localization (GO:0051234),4653,570,419.1,+,1.36,1.24E-14,1.34E-12
transport (GO:0006810),4501,548,405.41,+,1.35,1.75E-13,1.70E-11
immune system process (GO:0002376),2849,345,256.61,+,1.34,5.78E-08,2.89E-06
regulation of multicellular organismal process (GO:0051239),2647,320,238.42,+,1.34,2.40E-07,1.08E-05
cellular macromolecule biosynthetic process (GO:0034645),1655,199,149.07,+,1.33,1.03E-04,2.56E-03
response to oxygen-containing compound (GO:1901700),1584,190,142.67,+,1.33,1.57E-04,3.69E-03
anatomical structure morphogenesis (GO:0009653),2135,256,192.3,+,1.33,8.70E-06,2.84E-04
nitrogen compound metabolic process (GO:0006807),6897,824,621.22,+,1.33,1.15E-20,2.51E-18
regulation of immune system process (GO:0002682),1701,202,153.21,+,1.32,1.77E-04,4.10E-03
macromolecule biosynthetic process (GO:0009059),1696,201,152.76,+,1.32,2.06E-04,4.69E-03
protein metabolic process (GO:0019538),4218,499,379.92,+,1.31,2.59E-10,1.77E-08
cellular response to chemical stimulus (GO:0070887),2898,342,261.02,+,1.31,6.53E-07,2.69E-05
cellular metabolic process (GO:0044237),7570,888,681.83,+,1.3,9.94E-21,2.27E-18
cellular developmental process (GO:0048869),3562,417,320.83,+,1.3,5.39E-08,2.71E-06
cell differentiation (GO:0030154),3509,410,316.06,+,1.3,9.17E-08,4.51E-06
system development (GO:0048731),4279,498,385.41,+,1.29,2.47E-09,1.46E-07
regulation of cellular process (GO:0050794),11302,1313,1017.98,+,1.29,2.83E-41,3.72E-38
primary metabolic process (GO:0044238),7363,854,663.19,+,1.29,3.89E-18,6.02E-16
animal organ development (GO:0048513),3187,369,287.05,+,1.29,1.21E-06,4.73E-05
cellular catabolic process (GO:0044248),1797,208,161.86,+,1.29,4.83E-04,9.80E-03
regulation of biological process (GO:0050789),11856,1366,1067.87,+,1.28,2.60E-43,5.12E-40
ion transport (GO:0006811),2881,331,259.49,+,1.28,1.07E-05,3.37E-04
cellular response to stimulus (GO:0051716),6770,774,609.78,+,1.27,2.68E-14,2.75E-12
biological regulation (GO:0065007),12571,1436,1132.28,+,1.27,4.55E-47,1.79E-43
organic substance metabolic process (GO:0071704),7878,895,709.57,+,1.26,5.87E-17,8.06E-15
anatomical structure development (GO:0048856),5266,597,474.31,+,1.26,1.19E-09,7.39E-08
developmental process (GO:0032502),5729,649,516.01,+,1.26,1.24E-10,8.91E-09
multicellular organism development (GO:0007275),4877,552,439.27,+,1.26,1.02E-08,5.61E-07
metabolic process (GO:0008152),8333,931,750.56,+,1.24,5.80E-16,7.20E-14
catabolic process (GO:0009056),2084,230,187.71,+,1.23,2.43E-03,3.84E-02
signal transduction (GO:0007165),5138,567,462.78,+,1.23,1.86E-07,8.49E-06
organonitrogen compound metabolic process (GO:1901564),5251,572,472.96,+,1.21,8.29E-07,3.35E-05
cell communication (GO:0007154),5572,604,501.87,+,1.2,5.74E-07,2.40E-05
signaling (GO:0023052),5485,593,494.04,+,1.2,1.17E-06,4.61E-05
response to stimulus (GO:0050896),8496,917,765.24,+,1.2,1.11E-11,9.40E-10
cellular biosynthetic process (GO:0044249),2709,290,244,+,1.19,3.09E-03,4.65E-02
organic substance biosynthetic process (GO:1901576),2804,299,252.56,+,1.18,3.17E-03,4.72E-02
cellular process (GO:0009987),15487,1626,1394.92,+,1.17,7.09E-38,6.99E-35
multicellular organismal process (GO:0032501),6909,687,622.3,+,1.1,2.50E-03,3.91E-02
biological_process (GO:0008150),17850,1773,1607.76,+,1.1,2.35E-35,1.95E-32
system process (GO:0003008),2040,132,183.74,-,0.72,6.76E-05,1.77E-03
cellular lipid metabolic process (GO:0044255),975,60,87.82,-,0.68,2.59E-03,4.02E-02
lipid metabolic process (GO:0006629),1222,75,110.07,-,0.68,5.90E-04,1.16E-02
cation transport (GO:0006812),826,45,74.4,-,0.6,4.22E-04,8.69E-03
nervous system process (GO:0050877),1380,61,124.3,-,0.49,6.75E-10,4.42E-08
transmembrane transport (GO:0055085),1292,57,116.37,-,0.49,1.97E-09,1.19E-07
G protein-coupled receptor signaling pathway (GO:0007186),1329,57,119.7,-,0.48,3.37E-10,2.26E-08
lipid catabolic process (GO:0016042),304,12,27.38,-,0.44,1.95E-03,3.18E-02
ion transmembrane transport (GO:0034220),1051,38,94.66,-,0.4,1.24E-10,8.89E-09
cation transmembrane transport (GO:0098655),637,23,57.37,-,0.4,8.49E-07,3.43E-05
positive regulation of cytosolic calcium ion concentration (GO:0007204),283,10,25.49,-,0.39,1.23E-03,2.17E-02
glycosylation (GO:0070085),255,9,22.97,-,0.39,2.21E-03,3.55E-02
inorganic cation transmembrane transport (GO:0098662),572,20,51.52,-,0.39,1.55E-06,5.91E-05
glycoprotein biosynthetic process (GO:0009101),300,10,27.02,-,0.37,5.33E-04,1.06E-02
inorganic ion transmembrane transport (GO:0098660),664,22,59.81,-,0.37,6.56E-08,3.24E-06
protein glycosylation (GO:0006486),242,8,21.8,-,0.37,1.68E-03,2.82E-02
macromolecule glycosylation (GO:0043413),242,8,21.8,-,0.37,1.68E-03,2.81E-02
anion transmembrane transport (GO:0098656),458,15,41.25,-,0.36,9.22E-06,2.97E-04
organic anion transport (GO:0015711),340,11,30.62,-,0.36,1.22E-04,2.96E-03
glycoprotein metabolic process (GO:0009100),372,12,33.51,-,0.36,5.09E-05,1.37E-03
Unclassified (UNCLASSIFIED),2745,82,247.24,-,0.33,2.35E-35,2.06E-32
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),259,7,23.33,-,0.3,2.79E-04,6.11E-03
humoral immune response (GO:0006959),386,10,34.77,-,0.29,3.06E-06,1.08E-04
detection of stimulus (GO:0051606),718,18,64.67,-,0.28,3.40E-11,2.60E-09
aminoglycan metabolic process (GO:0006022),166,4,14.95,-,0.27,2.86E-03,4.36E-02
electron transport chain (GO:0022900),170,4,15.31,-,0.26,2.03E-03,3.29E-02
sensory perception (GO:0007600),973,22,87.64,-,0.25,2.55E-16,3.24E-14
visual perception (GO:0007601),216,4,19.46,-,0.21,1.01E-04,2.54E-03
sensory perception of light stimulus (GO:0050953),220,4,19.82,-,0.2,7.03E-05,1.84E-03
terpenoid metabolic process (GO:0006721),124,2,11.17,-,0.18,2.93E-03,4.45E-02
mitochondrial gene expression (GO:0140053),140,2,12.61,-,0.16,1.03E-03,1.89E-02
isoprenoid metabolic process (GO:0006720),143,2,12.88,-,0.16,6.92E-04,1.33E-02
complement activation (GO:0006956),177,2,15.94,-,0.13,5.33E-05,1.43E-03
respiratory electron transport chain (GO:0022904),108,1,9.73,-,0.1,1.44E-03,2.47E-02
neuropeptide signaling pathway (GO:0007218),109,1,9.82,-,0.1,1.45E-03,2.48E-02
glycolipid metabolic process (GO:0006664),110,1,9.91,-,0.1,1.47E-03,2.51E-02
detection of stimulus involved in sensory perception (GO:0050906),554,5,49.9,-,0.1,4.48E-15,4.94E-13
liposaccharide metabolic process (GO:1903509),111,1,10,-,0.1,1.50E-03,2.55E-02
"complement activation, classical pathway (GO:0006958)",161,1,14.5,-,0.07,2.12E-05,6.27E-04
humoral immune response mediated by circulating immunoglobulin (GO:0002455),167,1,15.04,-,0.07,1.46E-05,4.50E-04
sensory perception of smell (GO:0007608),468,1,42.15,-,0.02,1.30E-16,1.70E-14
detection of chemical stimulus (GO:0009593),522,1,47.02,-,0.02,1.57E-18,2.53E-16
sensory perception of chemical stimulus (GO:0007606),542,1,48.82,-,0.02,1.94E-19,3.52E-17
"phagocytosis, recognition (GO:0006910)",106,0,9.55,-, < 0.01,2.42E-04,5.39E-03
ceramide metabolic process (GO:0006672),93,0,8.38,-, < 0.01,5.08E-04,1.02E-02
protein N-linked glycosylation (GO:0006487),75,0,6.76,-, < 0.01,2.61E-03,4.02E-02
mitochondrial respiratory chain complex assembly (GO:0033108),101,0,9.1,-, < 0.01,3.59E-04,7.58E-03
proteoglycan metabolic process (GO:0006029),85,0,7.66,-, < 0.01,1.16E-03,2.07E-02
detection of chemical stimulus involved in sensory perception of smell (GO:0050911),441,0,39.72,-, < 0.01,4.25E-17,5.93E-15
detection of chemical stimulus involved in sensory perception (GO:0050907),486,0,43.77,-, < 0.01,6.63E-19,1.11E-16
mitochondrial ATP synthesis coupled electron transport (GO:0042775),89,0,8.02,-, < 0.01,7.65E-04,1.46E-02
ATP synthesis coupled electron transport (GO:0042773),90,0,8.11,-, < 0.01,7.75E-04,1.47E-02